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     The function of neural network is based on the regulated release of neurotransmitters 
by exocytosis and the subsequent recycling of synaptic vesicles (SV) membranes and 
proteins by endocytosis. The nascent SVs can be generated from plasma membrane or 
endosome-like vacuoles, however, the exact mechanism of SV recycling and the role of 
endosomes in this process are controversial. Furthermore, an essential element for 
maintaining neural networks is the regulation of neurotransmission through mechanisms of 
pre- and postsynaptic plasticity as well as homeostatic scaling, a process in which the 
activity-dependent changes of postsynaptic receptors lead to adaptive adjustment of the 
presynaptic neurotransmitter release. Whether and how the presynaptic neurotransmitter 
release is controlled intrinsically in an activity-dependent manner has not yet been fully 
understood. In my work, I examined the physiological function of the endosomal signal lipid 
phosphatidylinositol 3-phosphate [PI(3)P], a putative factor for regulation of SV recycling 
and control of presynaptic neurotransmission. By combining acute pharmacological and 
chemical-genetic approaches, I was able to show that excitatory neurotransmission and 
synaptic vesicle cycle are controlled by PI(3)P levels. Neuronal activity or pharmacological 
inhibition of PI 3-Kinase VPS34 lead to a drastic reduction in PI(3)P synthesis. PI(3)P 
reduction further inhibits excitatory neurotransmission and affects SV exo-/endocytosis. 
Conversely, silencing of neural network activity leads to increased PI(3)P levels. I was also 
able to show that the inhibition of exocytosis and endocytosis SV due to reduced PI(3)P 
levels is based on the Rab5-mediated hyperactivation of calcium-dependent protease calpain. 
Calpain-mediated cleavage and activation of the regulatory p35 subunit of the 
cyclin-dependent kinase 5 (Cdk5) is in turn responsible for the inhibition of exo- and 
endocytosis SV. As part of my doctorate, I was able to decipher an unexpected and novel 
function of the endosomal lipid PI(3)P in the control and scaling of the excitatory 
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neurotransmission and thus neural network activity. This mechanism could explain the 
essential role of VPS34 in the development of the central nervous system as well as in 





     Die Funktion neuronaler Netzwerke basiert auf der regulierten Freisetzung von 
Neurotransmittern durch Exozytose und nachfolgendes Recycling Botenstoff enthaltender 
Synaptischer Vesikel (SV) durch Endoztyose und Budding naszenter SV aus 
endosomenartigen Vakuolen. Der genaue Mechanismus des Recyclings SV und die Rolle 
von Endosomen in diesem Prozess sind umstritten. Ein wesentliches Element der Funktion 
neuronaler Netzwerke ist die Regulation der Neurotransmission durch Mechanismen der prä- 
und postsynaptischen Plastizität sowie durch homeostatisches Scaling, ein Prozess bei der 
die Änderungen in der Aktivität postsynaptischer Rezeptoren zu adaptiven Anpassungen der 
präsynaptischen Neurotransmitterfreisetzung führen. Ob und wie die präsynaptische 
Neurotransmitterausschüttung intrinsisch aktivitätsabhängig kontrolliert wird, ist bislang 
unvollständig verstanden. In meiner Arbeit habe ich die physiologische Funktion des 
endosomalen Signallipids Phosphatodylinositol 3-Phosphat [PI(3)P], eines putativen Faktors 
im Recycling SV Membranen, in der SV Exo- und Endoztyose sowie der Kontrolle der 
präsynaptischen Neurotransmission untersucht. Ich konnte durch Kombination akuter 
pharmakologischer und chemisch-genetischer Ansätze zeigen, dass die exzitatorische 
Neurotransmission und der synaptische Vesikelzyklus durch PI(3)P kontrolliert werden. 
Neuronale Aktivität oder pharmakologische Hemmung der PI 3-Kinase VPS34 führen zu 
einer drastischen Reduktion der PI(3)P Synthese und inhibieren die exzitatorische 
Neurotransmission sowie die SV Exo-/Endozytose. Silencing der neuronalen 
Netzwerkaktivität führt umgekehrt zu erhöhten PI(3)P Levels. Ich konnte ferner zeigen, dass 
die Inhibition der Exo- und Endozytose SV infolge reduzierter PI(3)P Levels auf der 
Rab5-vermittelten Hyperaktivierung der Protease Calpain beruht. Calpain-vermittelte 
Spaltung und Aktivierung der regulatorischen p35 Untereinheit der Cyclin-abhängigen 
Kinase 5 (Cdk5) ist wiederum für die Inhibition der Ex- und Endozytose SV verantwortlich. 
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Damit ist es mir gelungen, im Rahmen meiner Promotion eine unerwartete und neuartige 
Funktion des endosomalen Lipids PI(3)P in der Kontrolle und Skalierung der exzitatorischen 
Neurotransmission und damit der neuronalen Netzwerkaktivität zu entschlüsseln. Dieser 
Mechanismus könnte die essentielle Rolle von VPS34 in der Entwicklung des 





1.1 Neurotransmission and synaptic vesicle recycling 
The mammalian brain is a complex network of specialized cells, such as glial cells 
and neurons. While glial cells support neuronal function, neurons are the main cell type that 
processes, stores and transmits information in the brain. Neurons are composed of four 
morphologically defined regions: The soma, dendrites, the axon, and synaptic terminals. 
Each region has its distinct role in signaling and communicating with other neurons. To 
maintain the neural network, neurotransmission is a fundamental process that drives 
information transfer between neurons. It requires the physical coupling and coordinated 
activity of pre- and post-synaptic compartments (Thomas Biederer, Pascal S. Kaeser, 2017). 
When an action potential (AP) arrives at the presynaptic terminal, signaling molecules called 
neurotransmitters that are stored in synaptic vesicles (SVs), are released by exocytosis into 
the synaptic cleft (Südhof and Rizo, 2011). Depending on the nature of the neurotransmitter 
and the type of postsynaptic receptors that they bind to, neurotransmitter release can regulate 
the activity of brain circuits by either facilitating or hindering action potential propagation. 
(Fon and Edwards, 2001).  
SVs are small and complex organelles with an uniform diameter of approximately 40 
nm. They contain numerous proteins which are required for membrane trafficking, fusion 
and neurotransmisster uptake (Takamori et al., 2006). SV recycling is a key process for 
sustained neurotransmission. Readily releasable synaptic vesicles are clustered at a 
specialized region of presynaptic membrane called active zone (AZ) (Südhof, 2012). Due to 
its small size, presynaptic terminals contain a limited number of SVs. Therefore, sustained 
neurotransmission may very rapidly deplete SVs in the absence of an efficient SV 
reformation mechanism. SVs have a well-defined protein composition and homogenous size, 
suggesting that a rigorous SV reformation mechanism is required to maintain the releasable 
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pool of SVs (Heuser and Reese, 1973; Milosevic, 2018). During presynaptic activity, 
voltage-gated calcium channels open and allow Ca2+ to enter presynaptic terminals. The 
rising Ca2+ concentration at the AZ triggers SV fusion with plasma membrane to release the 
neurotransmitters. After SV fusion, SV endocytosis retrieves the excess plasma membrane 
and synaptic proteins to maintain membrane surface area and to locally generate new SVs in 
the presynaptic compartment (Figure 1.1; Soykan et al., 2016). Depending on the type of 
synapses and firing pattern, different modes of SV endocytosis with different time constants 
have been proposed: classical clathrin-mediated endocytosis (CME), an alternative 
clathrin-independent endocytosis (CIE) pathway, rapid kiss-and-run exo-endocytosis, and 
activity-dependent bulk endocytosis. However, the exact nature and mechanism of various 
modes of SV recycling require more studies (Kokotos and Cousin, 2015; Soykan et al., 2016; 











Figure 1.1. Proposed modes of SV endocytosis.  
(a) Full fusion of SV and followed by clathrin-coated vesicle reform from the plasma 
membrane. (b) After SV exocytosis followed by a large invagination reformation on the 
membrane, and further recruit clathrin and other SV proteins to reform SVs. (c) Opening and 
closure of SV fusion pore directly occur on the AZ. (d) Bulk membrane internalize at the AZ. 
(Soykan et al., 2016) 
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1.1.1 Clathrin-mediated endocytosis 
Clathrin-mediated endocytosis (CME) is a well-studied and classical pathway for SV 
cycling. After SV fusion, the membrane and synaptic proteins are integrated into plasma 
membrane, and subsequently followed by clathrin-dependent endocytosis to maintain 
membrane integrity. The process starts with the recruitment of clathrin adaptors onto 
phosphatidylinositol (4,5)-biphsophate [PI(4,5)P2]-positive plasma membrane. Adaptor 
proteins initiate recruitment of clathrin triskelia around a budding vesicle, resulting in the 
clathrin-coated pit formation. The fission event is triggered by the GTPase dynamin at the 
neck of pit. After fission, the coated vesicle is internalized into the synapse and rapidly loses 
its coat via the action of Auxilin, the ATPase Hsc70 and Synaptojanin-1, a phosphatase that 
hydrolyzes PI(4,5)P2 to promote the dissociation of adaptors. Synaptic proteins and lipid 
molecules are involved in the regulation of CME, for instance, Bin/Amphiphysin/RVS (BAR) 
domain-containing proteins that bind to phosphoinositides (PIPs) and are involved in 
curvature generation and stabilization (Figure 1.2). However, in contrast to the very rapid 
response of SVs to physiological action potential stimulation, CME is a relatively slow 
process that may be too slow to internalize proteins from the plasma membrane and support 
the recovery of vesicle pools. Besides, several studies showed that SV recycling was not 
fully impaired in clathrin-depleted neurons (Kononenko et al., 2014; Soykan et al., 2017), 
suggesting there is another pathway may involve in SV recycling (Watanabe and Boucrot, 
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Figure 1.2. Mode of Clathrin-mediated endocytosis.  
Clathrin and adaptor proteins are recruited to the endocytic vesicles. (Milosevic, 2018)    
  
1.1.2 Clathrin-independent fast endocytosis 
This pathway was first identified in the Caenorhabditis elegans neuromuscular 
junction (Watanabe et al., 2013a) and in cultured mammalian hippocampal neurons 
(Watanabe et al., 2013b). After SV fusion, a large invagination is generated from the plasma 
membrane by clathrin-independent endocytosis (CIE), and clathrin and its adaptors are 
subsequently recruited to endosome-like structures to reform new SVs (Kononenko et al 
2014) (Figure 1.1b). The CIE pathway highly depends on the fission activity of dynamin and, 
possibly, physiological temperature, and can be completed in less than a second. Thus, it was 
considered as a faster endocytic mechanism for excessive membrane and SV proteins 
retrieval (Watanabe et al., 2013b). This endocytic pathway does not require clathrin. The 
amount of membrane exocytosed equals the amount of internalized membrane, indicating 
that this pathway is compensatory and likely a major mechanism for SV endocytosis 
(Watanabe et al., 2013b). However, it was later shown that SVs are endocytosed over many 
seconds in response to AP trains, while only minor portion of SV proteins are rapidly 
internalized in millisecond timescale at physiological temperature. It is further suggested that 
CIE has a limited capacity and is capable of compensating for small number of SVs fused 
upon a single or few APs in mammalian hippocampal neurons (Soykan et al., 2017). Given 
that this mode of endocytosis is triggered very rapidly after SV fusion, it may serve crucial 
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roles in removing the excess membrane from the surface of the synaptic terminal for 
maintaining membrane homeostasis and allow for further vesicle fusion. How this pathway 
is kinetically controlled needs to be addressed further. 
 
1.1.3 Kiss-and-run 
Kiss-and-run has been observed in neuroendocrine cells as an alternative 
clathrin-independent rapid mechanism to retrieve membrane and proteins without full 
collapse of SVs at the active zone (Figure 1.1c). In this mechanism, a vesicle transiently 
contacts the plasma membrane followed by opening and closing of a fusion pore at the same 
site. The vesicle is quickly recycled to the cytoplasm after closure of fusion pore (Wen et al., 
2017). Even though hormone or peptide secreting large dense core vesicles favor this mode 
of membrane recycling, it remains to be proven whether SVs dominantly or partly use the 
kiss and run route. 
 
1.1.4 Activity-dependent bulk endocytosis  
To prevent complete breakdown of synaptic architecture and neurotransmission upon 
sustained and strong stimulation, neurons utilize activity-dependent bulk endocytosis 
(ADBE) to eliminate excessive membrane. This pathway can serve as an emergency 
response to high intensity stimulation. Strong stimulus drives Ca2+ influx into synapse and 
activates ADBE sensor Calcineurin, a phosphatase for dephosphorylation of SV proteins, 
that dephosphorylates Dynamin, and further trigger membrane curvature and tabulation for 
generating bulk membrane invaginations from the plasma membrane (Figure 1.1d). ADBE 
retrieves large regions of plasma membrane at the periactive zone, and then invaginations are 
transformed into bulk endosomes, which recruit clathrin and its adaptors for SV generation 
(Cousin, 2015).  
Despite many studies on identifying the precise mechanism of SV recycling, many 
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key questions remain controversial. It is possible that the dominant mode of SV recycling 
and membrane retrieval depends on the neuron or synapse type and its activity pattern. In 
general, SVs are endocytosed via CME and CIE during moderate activity levels, whereas 
ADBE operates only during high activity. At physiological temperature, CIE is the 
predominant mechanism for SV cycling after brief neuronal activity (Watanabe et al., 2014) 
or high frequency stimulation (Soykan et al., 2017). Regardless of different modes of SV 
entry, endocytic vesicles at the presynaptic terminal are usually delivered to the 
endosome-like structures. 
 
1.2 Synaptic vesicle reformation from endosome-like structures 
After stimulation, a dynamic population of endosome-like structures are generated 
either by strong and sustained stimulation through ADBE, or following weak and brief 
stimulation by CIE. It remains to be fully investigated whether these endosome-like 
structures have the true characteristics of a classical early endosomes. Conventionally, 
classical endosomes are considered as stable organelles that serve as sorting platforms for 
endocytic proteins and lipids (Huotari and Helenius, 2011). Cargo sorting on endosomes 
requires numerous protein and lipid machineries which are involved in fission of endosomal 
intermediates, fusion with other endosomes or with autophagosomes and lysosomes for 
degradation. The phospholipid phosphatidylinositol 3-phosphate [PI(3)P], the major 
phosphoinositide residing on endosomes, the PI(3)P-binding protein EEA1 and Rab family 
protein Rab5 are important factors for endosome maturation, cargo trafficking and cellular 
signaling (Gautreau et al., 2014). Classical Rab5-positive, PI(3)P-containing endosomes 
have been observed at presynaptic terminals of Drosophila. These endosomes have been 
found to have important roles in determining neurotransmitter release probability and 




In contrast to classical endosomes, endosome-like structures that are formed at the 
synapse soon after SV fusion appear to be more transient in nature. Although these 
endosome-like structures disappear rapidly, they may play a crucial role in SV recycling and 
degradation of membrane proteins (Saheki and De Camilli, 2012). Despite years of research 
on endosomal membrane trafficking, little is known regarding the function of bona fide 
endosomes or endosome-like structures at the synapse and how they precisely contribute to 
SV recycling. A key question is whether these endosome-like structures contain classical 
endosomal PI(3)P or whether they maintain plasma membrane properties (e.g., PI(4,5)P2) for 
a short time frame and participate in SV reformation. To date, synaptic endosomes are seen 
either as stable organelles, or as short-lived intermediates formed by homotyptic fusion of 
vesicles or intermediates of SV recycling. It is also known that neuronal synapses contain 
several endosomal proteins, for example Rab5, Rab7, Rab11 and APP-like protein (Rodal et 
al., 2011; Takamori, 2016; Wucherpfennig et al., 2003). Thus, many questions about the role 
of synaptic endosomal compartment and its role in SV recycling require further 
investigation.  
 
1.3 Endosomal phosphatidylinositol 3-phosphate and VPS34 
Phosphoinositides (PI) are short-lived membrane phospholipids which are involved 
in several cellular signaling pathways, development, cytoskeleton regulation as well as 
intracellular membrane trafficking (Di Paolo and De Camilli, 2006). Phosphorylation of the 
inositol ring of phosphatidylinositol at the 3-position generates phosphatidylinositol 
3-phosphate [PI(3)P], a key component of endosomal membrane. PI(3)P is mainly 
synthesized by Class III PI3 kinase VPS34, and several studies have shown that PI(3)P is 













Figure 1.3. Mechanism of PI(3)P synthesis.  
PI(3)P is produced by Class II and Class III PI3-kinase. 3-Phosphatase can hydrolysis PI(3)P 
back into PI. PI(3)P can further convert to PI(3,4)P2 or PI(3,5)P2 by different kinases 
(Burman and Ktistakis, 2010). 
 
      Two major groups of PI(3)P-binding domains have been reported: FYVE domains, 
and Phox homology (PX) domains. Proteins containing these domains bind to PI(3)P with 
high affinity and are involved in various steps of intracellular trafficking. For example, 
FYVE-containing EEA1, an early endosomal protein, interacts with endosomal SNARE 
proteins and regulates endocytic membrane fusion through its recruitment by Rab5 and 
PI(3)P (Burman and Ktistakis, 2010).    
      VPS34 functions as two tetrameric complexes that consist of the catalytic subunit 
VPS34, regulatory subunit VPS15, the adaptor protein Beclin-1 and either ATG14L to form 
complex I, or UV irradiation resistance-associated gene (UVRAG) to form complex II. The 
distinct complexes have a multitude of functions in intracellular trafficking. For instance, 
complex I plays a role in autophagy, while complex II is involved in endosomal fusion and 
sorting, endosomal trafficking towards the lysosome as well as multivesicular body (MVB) 
formation (Backer, 2016; Marat and Haucke, 2016).  
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1.3.1 VPS34 complex and its regulatory subunits  
     The lipid kinases VPS34 subunit of complex I and II consists of a N-terminal 
C2 domain, a helical domain and a C-terminal kinase domain (Figure 1.4). The C2 domain is 
essential for complex assembly, and it can be phosphorylated by AMP-activated protein 
kinase (AMPK) (at T163) (Kim et al., 2013) or Cdk5 (at T159) (Furuya et al., 2010). These 
phosphorylations interrupt the interaction between subunits and thereby reduce VPS34 
activity. Another essential subunit VPS15, a common component of both complexes, is a 
regulator for VPS34 activity. VPS15 contains a N-terminal pseudokinase domain, a helical 
repeated HEAT domain and C-terminal WD40 domain which interacts with C2 domain of 
VPS34 and Rab5 on endosomes (Figure 1.4) (Murray et al., 2002). VPS15 mutations cause 
the instability of VPS34 complex which in turn perturbs the neuronal migration in mice 
(Gstrein et al., 2018). The other shared subunit of complex I and II is Beclin1, which is 
composed of a BH3 domain, two coil-coil domains and a membrane-binding BARA domain 
(Figure 1.4). The numerous posttranslational modifications of Beclin1 play crucial roles in 
mediating the specific function of different complexes, their localizations, binding partners 
and complex stabilities. For instance, the autophagy-promoting modifications are found in 
the BH3 domain (Abrahamsen et al., 2012; Kehrl, John and Shi, 2019; Russell et al., 2014), 
whereas autophagy-inhibiting modifications are mostly found in the coil-coil domain or the 
BARA domain (Munson et al., 2015). The autophagy-specific subunit ATG14L is the 
defining component for complex I. It consists of a ER-targeting N-terminal domain, three 
coil-coil domains, a C-terminal Backor/ATG14L autophagosome targeting sequence (BATS) 
domain (Figure 1.4). Phosphorylation of the BATS domain by mTOR inhibits autophagy (Xu 
et al., 2016). One the other hand, UVRAG is a component of the VPS34 complex II. It 
contains a proline-rich domain, a lipid-binding C2 domain, two coil-coil domains, a BARA2 
domain and a C-terminal domain (Figure 1.4). The UVRAG localizes on Rab5-positive 
endosomes as a part of complex II, and it can be phosphorylated by mTOR to inhibit 
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autophagosome maturation (Munson et al., 2015) (Ohashi et al., 2019).  
Structural and biochemical studies have identified many posttranslational 
modification sites in VPS34 complex I and II. The phosphorylation, ubiquitination and other 
modification of VPS34 complexes strongly affect their kinase activity and subcellular 
membrane binding ability. Also, several accessory proteins, including NRBF2, PAQR3, 
AMBRA1 and Rubicon, are associated with complex I or II to control their activity and 











Figure 1.4. Domain organization of VPS34 complexes. 
The domain structure of different subunits in VPS34 complex I and II. VPS, vacuolar protein 
sorting; WD40, approx. 40 amino acids that often ends with tryptophan (W) and aspartic 
acid (D); BECLIN, Bcl-2 interacting protein; C2, protein kinase C conserved region 2; ATG, 
Autophagy-related gene; BARA, beta-alpha repeated; BARKOR, Beclin 1-associated 
autophagy-related key regulator; C/C, coiled coil; UVRAG, UV radiation 
resistance-associated gene (Backer, 2016). 
 
1.3.2 VPS34 complex I and autophagy 
VPS34 is essential for autophagy, a degradation mechanism triggered by nutrient 
insufficiency, which removes unnecessary and dysfunctional cellular components. PI(3)P 
that is produced by VPS34 serves as a platform for autophagosome biogenesis (Backer, 
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2016). During autophagy, damaged or aged molecules are initially sequestered and 
surrounded by a flat membrane, which is followed by elongation and sealing of the 
membrane and leads to the formation of autophagosomes that are delivered to lysosomes for 
degradation. Autophagy cargo proteins are then digested by lysosomes to fuel new 
biosynthesis (Figure 1.5).  
The induction of autophagy is triggered by starvation, hypoxia or low energy, and is 
related to the regulation of mammalian target of rapamycin (mTOR) complex I (mTORC1) 
signaling. The interplay between three key kinases; mTOR itself, (AMPK) and ULK1 is 
important for autophagy induction (Alers et al., 2012). mTORC1 is activated when nutrients 
are available and promotes growth through increased protein translation (Sabatini, 2006). On 
the other hand, in starved cells, AMPK and ULK1 not only phosphorylate downstream 
proteins to induce autophagy, but also phosphorylate Beclin1 for VPS34 activation and 
autophagosomal PI(3)P synthesis (Figure 1.5). The ATG14 subunit of VPS34 complex I is 
required for targeting the complex to ER and pre-autophagosomal structure, and involved in 














Figure 1.5. Schematic of autophagy mechanism.  
Autophagy is triggered by mTOR and AMPK, subsequcent PI(3)P production recruits PI(3)P 
binding protein to the membrane. Autophagic substrates are packaged into autophagosome, 
which were then fused with lysosome for degradation (Lieberman andSulzer, 2020).   
 
Maintaining protein and organelle quality and preventing misfolded protein 
accumulation in neurons are essential for neuronal function and preventing various forms of 
neurodegeneration. In neurons autophagosomes originate in the distal end of axons and 
undergo retrograde transport towards the proximal end of axons and soma where most 
lysosomes are located for degradation. On the other hands, autophagosomes in the soma are 
trafficked from the axon or generated locally in response to enhanced synaptic activity. 
These functions depend on the type and age of neurons, although the complexity of 
autophagic activity in the brain requires further study (Kulkarni et al., 2018).  
      Recent works has shown that autophagy has roles in pre- and postsynaptic functions 
during normal development and in disease. In Drosophila, overexpression of Atg1, a 
homolog of ULK1, causes an increased number of synaptic sites, whereas loss of autophagy 
decreases size of neuromuscular junction (Shen and Ganetzky, 2009). More studies 
suggested that autophagy shapes neurotransmission. Ultrastructural analysis of 
autophagy-deficient dopaminergic neurons showed enlarged presynaptic terminals and 
changes in morphology and number of synapses (Hernandez et al., 2012). suggesting that 
autophagy has roles in homeostasis of SVs and neurotransmitter release (Figure 1.6). 
Autophagy is also implicated in the clearance of damaged SV proteins. It has been proposed 
that a highly regulated clearance system is required for neurons to maintain the synapse 













Figure 1.6. The roles of autophagy in pre- and postsynaptic functions. 
Autophagy can control neurotransmission at both pre- and postsynapses. The presynaptic, 
autophagy controls SV homeostasis and release as well as mitochondrial function. The 
postsynaptic autophagy regulates excitatory neurotransmission by degrading AMPA and 
GABAA receptors. Autophagy modulates synaptic plasticity, neuropeptide signaling, synapse 
formation, and synaptic pruning (Lieberman andSulzer, 2020). 
 
1.3.3 The role of VPS34 complex II in the endosomal system  
     VPS34 complex II is recruited to early endosome through early endosomal GTPase 
Rab5 and VPS15 interactions, and it locally generates more PI(3)P on endosomal membrane. 
Rab proteins, such as Rabenosyn-5 and Rabankyrin-5, and EEA1 interact with Rab5 and 
PI(3)P via FYVE domains. The assembly of early endosomal proteins are involved in the 
regulation of endosomal docking and fusion. The conversion of PI(3)P into other 
phosphoinositides are involved in endosomal maturation along the early endosome/late 
endosome/lysosome pathway. The transition between early and late endosomes is mediated 
by Rab5 to Rab7 conversion, and interaction between VPS34-VPS15 and Rab7 is crucial for 
endosome maturaton (Poteryaev et al., 2010). Additionally, EEA1 interacts with SNARE 
proteins (soluble NSF-attachment protein receptor) Syntaxin-6 and Syntaxin-13 to regulate 
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vesicle docking and priming during early endosomal fusion (McBride et al., 1999; Simonsen 
et al., 1999). 
      Besides, Retromer complex is localized at endosomal compartment, and VPS34 
complex II is required for the function of the Retromer complex that is involved in 
retrograde trafficking of endocytic cargos to the Golgi compartment (Figure 1.7). Retromer 
regulates the homeostasis of many endosome-related transmembrane proteins. Mutations in 
Retromer complex cause defects in protein turnover that are implicated in neurodegenerative 
diseases (Vilariño-Güell et al., 2011). Retromer complex is composed of three core proteins, 
VPS35, VPS29 and VPS26, and membrane-associated sorting nexin dimer (SNX1, SNX2, 
SNX5 and SNX6) that mediates endosomal membrane targeting through a PI(3)P binding 
PX domain The association of Retromer with endosomes also requires Rab7, which plays a 
central role in the retrieval of different cargo proteins from endosome to trans-Golgi network 
(Seaman et al., 1997; Wang et al., 2018)  
In addition to Retromer complex, VPS34 complex II is also involved in the assembly 
of ESCRT (endosomal sorting complexes required for transport) machinery, that plays a vital 
role in multivesicular body (MVB) biogenesis, cytokinetic abscission and viral budding 
(Wollert et al., 2009). In this pathway, VPS34 produces PI(3)P which then recruits the 
ESCRT-0 protein Hrs to the endosome through a FYVE binding domain. Hrs is the initial 
factor for assembly of ESCRT subcomplexes (ESCRT-I, -II, -III and VPS4) that drives 
internalization of ubiquitinated membrane proteins into intraluminal vesicles (ILVs) of 
MVBs, and finally leads to lysosomal degradation. ESCRT dysfunction is associated with 
numerous diseases, such as cancer and neurodegeneration (Henne et al., 2011) 
      In summary, generation of PI(3)P by VPS34 plays important roles in cellular mTOR 
signaling, endocytic protein trafficking as well as autophagy (Figure 1.7). VPS34 
knockdown or conditional knockout mice have shown that VPS34 plays critical roles in 
different tissues or organs, which are highly linked to human disease, especially 
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neurodegeneration and autism (Inaguma et al., 2016; Miranda et al., 2018). However, only 
few studies have addressed the role of VPS34 in neurons and its contribution to neuronal 












Figure 1.7. Classical functions of VPS34.  
PI(3)P is synthesized by VPS34 in intracellular membrane. VPS34 complex I is involved in 
autophagosome formation, while VPS34 complex II regulates fusion and maturation of 
Rab5-positive early endosome, mediates endosome to Golgi retrograde transport, and 
ESCRT complex (Backer, 2016).  
 
1.3.4 Dysregulation of PI(3)P levels in the nervous system 
     Neurons are susceptible to any disruption of endocytic or autophagic pathways. 
Several studies have demonstrated that genetic mutations in ubiquitous proteins which 
regulate endocytic or autophagic events result in various forms of neurodegeneration. 
Phosphoinositides are crucial for diverse membrane trafficking mechanisms. For example, 
mutation of the PI 3-phosphatase myotubularin-1 (MTM1) causes X-linked centronuclear 
myopathy, whereas its homologs MTMR-2, MTMR-13 and FIG4 which drive 
dephosphorylation of PI(3,5)P2 into PI(3)P, or PI(3)P into PI, are implicated in 
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Charcot-Marie-Tooth peripheral neuropathies, suggesting that an imbalanced 
PI(3)P-PI(3,5)P2 or PI-PI(3)P conversion may lead to neuromuscular disorders (Nicot and 
Laporte, 2008).  
      In addition, PI(3)P has been reported to be localized at dendrites, axons and synapses 
in hippocampal neurons. A study has showed that additional application of membrane 
permeable PI(3)P-AM in cultured hippocampal neurons promoted the formation of gephyrin 
clusters, a scaffold protein of inhibitory postsynapses, and accompanied with an increase in 
postsynaptic GABA receptors. This study suggested that endosomal PI(3)P is required for 
clustering of GABA receptors and the regulation of the synaptic strength at inhibitory 
postsynapses of hippocampal neurons (Papadopoulos et al., 2017). Some patients with 
learning disorder have been showed to carry genetic microdeletion of VPS34, suggesting 
that VPS34 is essential for brain development (Inaguma et al., 2016). Also, the 
polymorphisms in the VPS34 promoter region were reported to associate with schizophrenia 
and bipolar diseases (Stopkova et al., 2004).  
Furthermore, several studies based on conditional VPS34 deficient mice have 
shown that VPS34 deletion in sensory and pyramidal neurons lead to loss of dendritic spines, 
decreased number of synapses, gliosis and neurodegeneration, which were linked to defects 
in the endosomal system but not in autophagy (Wang et al., 2011; Zhou et al., 2010). Besides, 
recent studies have shown that selective depletion of PI(3)P can be found in the brains of 
human patients or mouse models of Alzheimer’s disease. Disruption of neuronal VPS34 
impairs autophagy, lysosomal degradation and causes endolysosomal membrane damage. 
PI(3)P deficiency due to loss of VPS34 activity also affects APP processing, which is 
associated with Alzheimer’s disease (Miranda et al., 2018; Morel et al., 2013). Intriguingly, 
the hallmarks of Alzheimer’s disease include presence of neuronal plaques composed of 
amyloid beta, intracellular neurofibrillary tangles containing hyperphosphorylation of tau 
protein, and these phenotypes are accompanied with abnormal activity of Calpain in 
26 
 
pathological conditions (Zheng et al., 2002)  
 
1.4 Abnormal Calpain activity in neurodegeneration  
In addition to the role of VPS34 and PI(3)P in neurodegeneration, a number of 
pathological conditions have been associated with abnormal Calpain activity, including 
Parkinson’s disease, Alzheimer’s disease, ischemia, stroke and brain trauma (Zatz and 
Starling, 2005). Calpains are calcium-dependent cysteine proteases that regulate cellular 
functions via a unique posttranslational proteolytic modification. Two well-studied 
ubiquitous Calpains, Calpain1 and Calpain2, are highly expressed in the central nervous 
system, and are crucial for neuronal function. More than 200 Calpain substrates have been 
identified in neurons, such as membrane receptors, cytoskeleton, postsynaptic density 
proteins, kinases and phosphatases which are localized at nerve terminals (Wu and Lynch, 
2006). Calpain-mediated synaptic protein cleavage plays important roles in the regulation of 
synaptic processes, not only in physiological states but also in pathological conditions.   
 
1.4.1 The regulation of Calpain activity 
Calpain1 and Calpain2 (also called µ-Calpain and m-Calpain, respectively) are two 
major Calpains expressed in neurons. Calpain activity is triggered by calcium binding: 
Calpain1 requires 3-50 µM calcium, whereas Calpain2 requires 0.4-0.8 mM calcium in vitro. 
Calpain has been identified as a phosphoinositide binding protein. The interaction between 
Calpain and charged membrane phospholipids such as phosphoinositides lowers the calcium 
requirement for Calpain activation (Shao et al., 2006). In the absence of an external stimulus, 
Calpains are diffusely distributed in the cytoplasm, while they change their localization and 
bind to the plasma membrane or organelle membranes upon sensing elevated intracellular 
calcium concentration (Hood et al., 2004; Mendoza et al., 2018; Michetti et al., 1996). To 
tightly regulate the activity of Calpain, Calpastatin is an endogenous inhibitor of Calpain, 
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which can bind to the substrate binding site of Calpain for activity inhibition (Goto et al., 
1994). The Calpastatin/Calpain ratio varies in different brain regions. Imbalanced 
Calpastatin/Calpain ratio has been found in mice with Alzheimer’s disease, suggesting that 












Figure 1.8. Opposite function of Calpain1 and Calpain2 in neurodegeneration 
Calcium influx activates Calpian1, which cleaves PHLPP1, resulting in activation of ERK 
and Akt for neuron protection. Activation of Calpain2 leads to p35 cleavage and hyperaction 
of cdk5, and finally lead to neurodegeneration (Huo et al., 2017).  
 
Additionally, Calpain1 and Calpain2 are believed to play opposite roles in 
neurodegeneration (Figure 1.8). After calcium triggered Calpain activation, Calpain1 cleaves 
PHLPP1 (PH domain and Leucine rich repeat Protein Phosphatase 1) which is a negative 
regulator of ERK and Akt, resulting in activation of ERK and Akt pathways and 
neuroprotection (Bickler and Fahlman, 2004). On the other hand, activation of Calpain2 
results in cleavage of STEP, leading to neurotoxicity (Xu et al., 2009). In particular, the 
Cdk5 activator p35 is cleaved by Calpain2 into p25, such that hyperactived cdk5/p25 induces 
tau hyperphosphorylation, that is a hallmark of Alzheimer’s disease (Huo et al., 2017; 
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Kimura et al., 2014) 
 
1.4.2 The Calpain2/p35-p25/Cdk5 pathway 
      As mentioned above, calcium influx through NMDA receptors activates Calpain2, 
resulting in conversion of the Cdk5-activator p35 to p25. p35 is a membrane-bound protein 
that consists of two parts, N-terminal p10 and C-terminal p25. The p10 region is 
myristoylated which is important for membrane targeting of p35, and p10 also contains a 
signal for p35 turnover (Figure 1.9). Cdk5 is autoinhibited via phosphorylation of p35, 
which leads to shorter half-life of p35, since this phosphorylation not only prevents the 
intramolecular cleavages of p35 into p25 and p10, but increases its proteasomal degradation 
(Kamei et al., 2007). However, when p35 is cleaved by Calpain2 to form p25 in certain 
pathological conditions, such as exposure to amyloid b peptide (Ab) and excitotoxicity, the 
degradation signal is lost and mistargeted p25/cdk5 becomes hyperactivate. p25/Cdk5 has an 
extended half-life thereby substantially extending the activation period of Cdk5. Under 
neurotoxic conditions, p25/Cdk5 induces tau hyperphosphorylation, which aggregates to 
form neurofibrillary tangles during the pathogenesis of Alzheimer’s disease (Kimura et al., 







Figure 1.9. Calpain/p35-p25/Cdk5 pathway.  
Cdk5 along is inactive, it needs to be activated by p35. Myristoylated p35 targets the whole 
complex to the membrane. P35-p25 conversion by Calpain leads to hyperactivation of Cdk5 
which is involved in several pathological condition (Kimura et al., 2014).  
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1.5 The role of Cdk5 in neuronal function 
      Cyclin-dependent kinase 5 (Cdk5) is a serine threonine kinase that functions in 
neuronal migration, neurite extension, pre- and postsynaptic synaptic transmission and 
synaptic plasticity. Cdk5 activity is limited in post mitotic neurons due to the absolute 
requirement of its regulatory factor p35. The association between Cdk5 and p35 induces a 
conformational change in the catalytic subunit of Cdk5 and results in induction of kinase 
activity (Tarricone et al., 2001). Dysregulation of Cdk5 is associated with neurodegenerative 
diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and some 
other brain disorders (McLinden et al., 2012).  
 
1.5.1 The role of Cdk5 in synaptic vesicle recycling 
      Cdk5 is a key factor to control synaptic vesicle exo- and endocytosis. Cdk5/p35 
interacts with multiple synaptic proteins to modulate exocytosis. For example, 
phosphorylation of Munc18 by Cdk5 disrupts its interaction with Syntaxin1A, which then 
affects their association with vesicular SNAREs, and facilitates exocytosis and 
neurotransmitter release (Fletcher et al., 1999). In addition, Cdk5 acts as a negative regulator 
of vesicle release: Inhibition of Cdk5 unlocks access to the resting vesicle pool, which 
normally stays stationary during neuronal activity, and causes a profound potentiation of 
presynaptic function. The balance between Cdk5 and Calcineurin, a calcium-dependent 
phosphatase that has an opposing function to Cdk5, is important for controlling the size of 
the recycling vesicle pool, and thus the release of neurotransmitter (Kim and Ryan, 2010).   
      In spite of the role in exocytosis, Cdk5 also participates in regulation of vesicle 
endocytosis (Figure 1.10). Cdk5 constitutively phosphorylates dephosphins such as 
Amphiphysin-1, Synaptojanin-1 and Dynamin-1 at rest. Amphiphysin-1 is a scaffold protein 
for Dynamin-1 recruitment, whereas Synatojanin-1 is required for vesicle uncoating. Upon 
presynaptic Ca2+ influx and neurotransmitter release, dephospin proteins are 
30 
 
dephosphorylated by the calcium-dependent phosphatase Calcineurin to trigger SV 
endocytosis. When synaptic activity stops the dephosphins are phosphorylated again by 
Cdk5. This phosphorylation/dephosphorylation cycle is mediated by the balance between 








Figure 1.10. The phosphorylation cycle in SV endocytosis.  
In the resting state, dephosphin proteins are phosphorylated (left), and SV are stored at 
synaptic terminals. After exocytosis, Calcineurin rapidly dephosphorylates dephosphin 
proteins and triggers SV endocytosis (middle). After repolarization, Cdk5 rephosphorylates 
dephosphins makes neuron back to resting state (Samuels and Tsai, 2003).   
 
1.5.2 The role of Cdk5 in neurotransmission 
Apart from its cricital role in regulating neurotransmitter release and SV recycling, 
Cdk5 also controls the postsynaptic receptor function in different types of neurotransmission. 
For example, Cdk5 activation is required for acetylcholine (Ach) receptor clustering and 
signaling in neuromuscular junction and motor axons (Fu et al., 2005). In the glutamatergic 
postsynapse, Cdk5 phosphorylates NR2A, a subunit of NMDA-type glutamate receptors, to 
increase channel activity which is important for induction of long-term potentiation (LTP) in 
the hippocampal CA1 region. Conversely, Cdk5 inhibition facilitates NMDA-mediated 
glutamatergic neurotransmission in the striatum. Additionally, Cdk5 also phosphorylates 
PSD-95, a postsynaptic scaffold protein, to regulate the clustering and density of ionotropic 
glutamate receptors. Inhibition of Cdk5 also decreases NMDA receptor endocytosis 
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(Bianchetta et al., 2011). This up and down regulation of NMDA receptor trafficking to the 
surface by Cdk5 is important for dynamic synaptic changes and synaptic plasticity 
(McLinden et al., 2012).       
 
1.6 Homeostatic synaptic scaling and synaptic plasticity 
Synaptic plasticity is a way how neurons adapt their behavior to a changing 
environment through changes in synaptic number and strength, and therefore store 
information and contribute to learning. When hippocampal neurons were induced to fire 
more than normal, over firing returns to baseline level, and contrarily, if neuron firing rate is 
reduced over time, neurons compensate and restore firing via synaptic scaling and plasticity 
(Figure 1.11). The coordination and balance between excitatory and inhibitory 
neurotransmission modulates network activity (Turrigiano, 2012; Turrigiano and Nelson, 
2004). It is not surprising that varied homeostatic mechanisms are operated by neurons to 
adapt external perturbation and maintain stable firing rate. 
 
1.6.1 Synaptic scaling is tightly regulated in different type of synapses 
      Synaptic scaling is a form of synaptic plasticity in the central nervous system. 
Manipulation of neuronal activity induces bidirectional compensatory changes in the 
synaptic strength of glutamatergic neurons and this process is best understood for 
postsynapses. When hippocampal neurons are induced to fire more intensely, after a period 
of time neuronal firing returns to basal levels, and conversely, when neuronal firing rate is 
reduced over time, neurons compensate and restore the firing to normal levels (Turrigiano et 
al., 1998) (Figure 1.11). The activity-dependent up- or downscaling of synaptic strength 
regulates the number of the N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5- 
methyl-4-isoxazole-propionic acid (AMPA) receptors on the postsynaptic plasma membrane 
(Watt et al., 2000). This mechanism is highly dependent on calcium influx and operates via 
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CaMK (Calcium/Calmodulin-dependent protein kinase) or Polo-like kinase 2 (Plk2)-Cdk5 
pathway. Specifically, in the Plk2-Cdk5 pathway, calcium influx activates Plk2 and Cdk5 
and affects the phosphorylation and degradation of its downstream target SPAR, a 
postsynaptic RapGAP and scaffolding protein which is involved in growth of dendritic 
spines and of the postsynaptic compartment (Seeburg et al., 2008). The detailed cellular and 
molecular mechanisms require further studies in different type of neurons. 
Neural circuits are composed of different types of excitatory and inhibitory neurons. 
It is not surprising that the homeostatic plasticity rules are specific for particular types of 
synapses. In cortical neurons it has been reported that excitatory synapses that connect to 
excitatory pyramidal neurons are scaled up by activity blockade, whereas the same 
mechanism does not operate for excitatory synapses that provide input to inhibitory neurons. 
On the other hand, enhanced network activity increases excitatory transmission onto 
GABAergic interneurons and induces additional inhibition (Rutherford et al., 1998; 
Turrigiano et al., 1998). Although excitatory and inhibitory synapses have their distinct 
plasticity rules, an overall consistent homeostatic shift applies to balance between excitation 
and inhibition. This mechanism is crucial for stabilizing firing rates, maintaining the 
neuronal network and preventing excitotoxicity in response to changes in stimulation 























Figure 1.11. Controlling of neuronal firing through homeostasis synaptic plasticity.  
(A) Demonstration of firing rate is homeostatic regulated by neuronal networks. (B) 
Synaptic scaling contributes to firing rate homeostasis. Perturbed neuron activity triggers 
synaptic scaling, which reduce the strength at all synapses with high activity to return to 
baseline level (Turrigiano, 2012).      
 
1.6.2 Presynaptic homeostatic plasticity 
       Homeostatic plasticity is not only confined to the postsynaptic site, but can also 
affect the presynaptic machinery in a similar fashion. At the Drosophila neuromuscular 
junction, activity blockade by tetrodotoxin TTX or the AMPA receptor blocker NBQX leads 
to a 50% decrease of the readily releasable pool (RRP) and SV release probability, whereas 
elevation of synaptic activity causes a decrease in RRP size. This suggests that an 
activity-dependent bidirectional plastic regulation of neurotransmitter release is important 
for maintaining neuronal firing rates within certain boundaries (Moulder et al., 2006; Murthy 
et al., 2001). Besides, multiple studies have suggested that different SV pools are regulated 
by homeostatic adaption to the overall neuron activity (Figure 1.12). As discussed above, 
Cdk5 is a key player for controlling the recycling pool size during homeostatic plasticity. 
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The protein phosphatase Calcineurin antagonizes Cdk5 in the regulation of the total 
recycling pool size. Additionally, Cdk5 can phosphorylate voltage-gated Ca2+ channel to 
control homeostatic changes in evoked Ca2+ influx and basal neurotransmission (Jeans et al., 
2017; Tomizawa et al., 2002). Presynaptic homeostatic adaption is important for preventing 
the runaway excitation or excitotoxicity during physiological or pathological conditions such 
as seizures.   
 
Figure 1.12. Homeostatic changes of SV pool at presynapse.  
Neuron excitation reduce Ca2+ influx via P/Q type calcium channel and SV recycling pool, 
whereas silence led to increased ca2+ influx and elevated recycling pool at the presynaptic 
site (Jeans et al., 2017).  
 
      Defective homeostatic plasticity has been found in variety of animal models with 
neurological, neurodevelopmental and neuropsychiatric diseases. Especially, impaired 
homeostatic synaptic plasticity has been proposed to be a key factor for pathogenesis of 
Alzheimer’s disease. Additionally, the neuropsychiatric disorder Schizophrenia is also linked 
to dysfunction of synaptic plasticity. Impairment of certain neurotransmitter systems (e.g. 
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hyperdopaminergic and hypofunction of glutamatergic transmission) can be observed in 
patient or mouse models of schizophrenia, and manipulation of synaptic plasticity is 
considered as the treatment for mental disorders (Kavalali and Monteggia, 2020). Synaptic 
plasticity is important for reorganization of the structure, function and connection between 
neurons in response to stimulation, and it is necessary for brain development, homeostasis, 
memory and learning (Davis and Müller, 2015; Dhuriya and Sharma, 2020; Frere and 
Slutsky, 2018). Given that the importance of homeostatic synaptic plasticity, the detailed 
mechanisms and how signal cascade is triggered need to be answered. 
 
1.7 Aims of the study 
     Exo- and endocytic recycling of SVs is a key process for neurotransmission. Even 
though it is widely accepted that an endosome-like vesicle is commonly found in synaptic 
terminals and act as an intermediate recycling platform in many different modes of SV 
endocytosis, a clear picture on the exact function and the precise lipid composition of this 
structure is still missing. Given that endosomal PI(3)P serves as a hub for regulating different 
intracellular signaling pathway, it is possible that presynaptic endosomal PI(3)P has a role in 
controlling of neuronal activity.  
 The aims of this study were: 1) to identify synaptic PI(3)P in hippocampal neurons; 2) 
to investigate the role of PI(3)P-positive endosomes at the presynaptic terminals; 3) to 
understand the role of PI(3)P in SV recycling and how the levels of PI(3)P-positive 
endosomes correlate with neuronal activity. Based on our findings on the crucial role of 
PI(3)P in the maintenance of SV recycling and the regulation of PI(3)P levels by electrical 
activity, 4) we further investigated the molecular mechanism underlying PI(3)P-mediated 





2. Materials and Methods 
2.1 Preparation of primary hippocampal and cerebellar neuron cultures 
Primary hippocampal neurons were used for transfection, live-imaging, 
immunocytochemistry, and electron microscopy. The detection of synaptic protein levels by 
immunoblotting after pharmacological treatments were carried out using cerebellar neurons. 
To prepare neuronal cultures, hippocampus or cerebellum were surgically removed from 
postnatal mice at p1-3 or p6, respectively. The tissues were cut into small pieces, and were 
digested in trypsin and DNAase containing buffer for 15 min at 37°C (137 mM NaCl, 5 mM 
KCl, 7 mM Na2HPO4, 25 mM Hepes and pH 7.2). After digestion, the neurons were washed 
twice with HBSS with and without 20% FCS, and then followed by pipetting up and down in 
DNase containing dissociation buffer (25 mM MgSO4·7H2O in HBSS) into single neurons. 
Primary neurons were plated onto PLL-coated coverslips for 6-well plates and cultured in 
MEM medium (Thermo Fisher) containing 2% B27 and 5% FCS. The medium for cerebellar 
cultures additionally contained 25 mM KCl. All neuronal cultures were treated with 2 µM 
AraC to avoid astrocyte growth, and cultured at 37°C, 5% CO2. 
 
2.2 Calcium phosphate transfection 
Calcium phosphate method (Promega) were used for neuron transfection at DIV 7-9. 
Briefly, 2X HEPES buffer and 6 µg plasmid DNA were mixed with 250 mM CaCl2 and 
incubated for 20 min to have precipitate formation. In parallel, neurons were starved in 
osmolarity-adjusted by D-mannitol (Sigma-Aldrich), serum-free NBA medium (Gibco) at 
37°C, 5% CO2. Precipitates were added to the neurons and incubated for 30 min at 37°C, 5% 
CO2. Finally, the coverslips were washed twice with osmolarity-adjusted HBSS (Gibco) and 




2.3 Live imaging of synaptic vesicle exo- and endocytosis via pHluorins 
pHluorin-based assays (e.g. Synaptophysin-pHluorin, vGlut1-pHluorin or 
Synaptotagmin-pHluorin) were used for tracking kinetics of SV exo-/ endocytosis. Cultured 
hippocampal neurons at DIV12-14 were pre-incubated with different inhibitors for 1 h and 
placed into an RC-47FSLP stimulation chamber (Warmer instruments) for electrical field 
stimulation and imaged at 37°C in basic imaging buffer (3.5 mM KCl, 170 mM NaCl, 20 
mM N-Tris[hydroxyl-methyl]-methyl-2-aminoethane-sulphonic acid (TES), 5 mM glucose, 
0.4 mM KH2PO4, 5 mM NaHCO3, 1.2 mM Na2SO4, 1.2 mM MgCl2, 1.3 mM CaCl2 (or 4 
mM CaCl2 for 2AP stimulation), 50 mM AP5 and 10 mM CNQX, pH 7.4). To distinguish 
whether increased surface retention of pHluorin-tagged SV proteins is due to defective 
endocytosis or impaired re-acidification of endocytic vesicles, acid quench assays were 
performed by locally perfused neurons with acidic imaging buffer (where TES was replaced 
by 2-(N-morpholino) ethane-sulfonic acid, adjusted to pH 5.5) for 20 s before and after 
electrical stimulation. All images were obtained by epifluorescence microscopy (Nikon 
Eclipse Ti) using an eGFP filter set F36-526, 40Χ oil-immersion objective and a sCMOS 
camera (Neo, Andor), and analyzed by imageJ using custom-written macros. At least 10-20 
responded boutons were randomly selected for analysis. The surface normalized curve was 
obtained by normalization of the fluorescent changes to the average signal of the first 10 s 
before electrical stimulation, and the peak normalized traces were calculated by 
normalization of the signal to the first peak as 1. SV exocytosis was quantified by measuring 
the fold-change in fluorescence upon stimulation. SV endocytosis was quantified by two 
complementary methods: For brief stimulations (e.g. 2 APs) endocytic time constants were 
determined by fitting the kinetic data points to monoexponential [y0 - A*exp(-x/t)] with zero 
offset using Prism 5 (Graphpad) software. For stimulations with multiple trains (e.g. 4 x 200 
APs or 4 x 50APs) the surface levels of SynaptopHluorin at 90 seconds after each 
stimulation was plotted. Surface retention was assessed by normalizing the surface pHluorin 
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levels to baseline fluorescence. For the acidic quench experiment, the acidic buffer-treated 
fluorescence was subtracted by the initial signals which were taken in neutral imaging buffer 
to obtain DF1, and the DF2 were calculated by subtraction of acidic buffer-treated 
fluorescence to the average signal of 10 s after 4 x 200 APs stimulation.  
 
2.4 Rescue of defective SV endpcytosis by membrane-permeant PI(3)P 
      Hippocampal neurons were transfected with Synaptohpysin-pHluorin at DIV7. 
Synthesized PI(3)P-AM (Subramanian et al., 2010) was dissolved in dry DMSO to a stock 
concentration of 40 mM and mixed with same volume of 10% pluronic F127 to enhance 
solubility. PI(3)P-AM is directly supplied together with 10 µM VPS34IN1 in growth 
medium and incubated with Synaptophysin-pHluorin-expressing neurons for 1 h prior to 
imaging by epifluorescence microscopy (Nikon Eclipse Ti).  
 
2.5 Immunocytochemistry of hippocampal neurons in culture 
For PI(3)P labeling, DIV 14 neurons were fixed with 2% PFA for 15min at room 
temperature, washed 3 times for 5 minutes with PBS containing 50 mM NH4Cl and 
permeabilized for 5 min by 20 µM Digitonin in buffer A (20 mM Pipes, 137 mM NaCl and 
2.7 mM KCl, pH 6.8). Excess Digitonin was removed by washing neurons in buffer A. To 
block the antibody epitopes and to label PI(3)P, neurons were treated with buffer A 
containing 5% normal goat serum and 0.05 mg/mL GFP-2XFYVE probe for 45 minutes. To 
remove the unbound probe, neurons were washed for 5 min with buffer A, followed by 1 h 
incubation with primary antibodies against GFP, MAP2 and Synaptophysin and a 45 min 
incubation with corresponding secondary antibodies coupled to Alexa Flour 488, 568 and 
647 (ThermoFisher) at room temperature. Unbound antibodies were removed by washing 
with buffer A after each steps. Stained neurons were post-fixed with 2% PFA for 5 min and 
mounted on glass slides using Immun-Mount (ThermoFisher). For Calpain2 and Rab5 
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staining, DIV14 neurons were fixed with ice-cold methanol for 3 min and with 2% PFA for 
15 min at room temperature. Neurons were then permeabilized for 5 minutes with 20 µM 
Digitonin in PBS and were blocked for 30 minutes by PBS containing 5% normal goat 
serum at room temperature, followed by overnight incubation with primary antibodies 
against Rab5, Calpain2, MAP2 and vGLUT1 at 4 °C, and then followed by 45 min 
incubation with Alexa Flour 488, 568 and 647-coupled secondary antibodies at room 
temperature. Neurons were washed twice with PBS after each steps, and mounted using 
Immu-Mount (ThermoFisher). Finally, all the neurons were imaged by spinning disk 
confocal microscopy (Ultraview ERS, Perkin Elmer) with Volocity software (Improvision, 
Perkin Elmer), and analyzed by ImageJ. For PI(3)P quantification, the cumulative intensity 
of fluorescence was obtained from mean intensity of selected region multiplied by 
thresholded positive area. To eliminate the difference of each experiments, the treated 
condition was normalized to control group. For Calpain and Rab5 quantification, the mean 
intensity was measured in MAP2-positive soma or vGlut1-positive synapses.  
 
2.6 Immunoblotting and quantification of protein content 
DIV7 cerebellar granule neurons were treated with different inhibitors for 1 h, and 
washed 2x with ice-cold PBS. Neuron lysates were harvested in sample lysis buffer (20 mM 
Tris pH 7.4, 1% SDS, 5% glycerol, 5mM β-mercaptoethanol, 0.01% bromophenol blue, 
0.3% protease inhibitor cocktail (Sigma-Aldrich) and phosphatase inhibitors (cocktails 2 and 
3, Sigma-Aldrich). Equal protein amounts of lysates were analyzed by SDS-PAGE and 
immunoblotting. Primary antibodies against various synaptic proteins were used in 
immunoblotting, followed by LI-COR 800CW and 680RD as secondary antibodies. 
Immunoblots were imaged by LI-COR system. The antibodies used in immunoblotting were 




2.7 Somatic and synaptic calcium measurement  
For somatic basal calcium, hippocampal neurons at DIV14 were treated with DMSO 
or 10µM VPS34IN1 for 1 h. 3µM Fluo4-AM (ThermoFisher) and 1% pluronic F-127 were 
applied in growth medium for 15 min. Coverslips were washed three times with growth 
medium, and imaged by epifluorescence microscopy (Nikon Eclipse Ti) using an eGFP filter 
set F36-526, 40Χ oil-immersion objective and a sCMOS camera (Neo, Andor), and analyzed 
by imageJ. The mean intensity was measured in each condition. To detect synaptic calcium, 
hippocampal neurons were transfected with sypHy-RGECO plasmid at DIV7, and imaged by 
epifluorescence microscopy. The mean intensity of RGECO-expressing synapses was 
measured in control and inhibitor-treated neurons. 
  
2.8 Quantification and statistics 
All data are presented as mean ± SEM, and are obtained from ≥ 3 independent 
experiments, with total sample number provided in figure legend. In the experiments that 
involve light or electron microscopy the statistical significance between two groups for all 
normally distributed data (e.g. effects of chemical inhibitors or genetic knockdowns on 
endocytic time constants, pHluorin surface retention levels, relative PI(3)P intensity) was 
evaluated with a two-tailed paired Student’s t-test. The statistical significance between more 
than two groups for all normally distributed data (e.g., percentage of pHluorin surface 
retention where inhibitor-treatment, protein overexpression and gene knockdown constructs 
are combined) was determined by two-way ANOVA using GraphPad6 (Prism). SigmaPlot 
(Systat Software Inc.) and IGOR Pro (WaveMetrics, Inc.) were used for electrophysiological 
data analyses and presentation. For PPF measurements significance was evaluated using Two 
Way RM ANOVA. For PS and polyspike amplitude and area measurements significance was 
evaluated using One Way ANOVA or student’s t-test. Significant differences were marked as 
*= p<0.05, **= p<0.01, ***= p< 0.001, ****= p< 0.0001.   
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2.9 Reagents for the study  
Reagent Source Identifier 
Plasmids     
Synaptophysin-pHluorin (Granseth et al., 2006) 
vGlut1-pHluorin (Voglmaier et al., 2006) 
Synaptotagmin-pHluorin (Wienisch andKlingauf, 2006) 
mRFP-FKBP-hMTM1 Addgene Cat#: 51614 
FRB*-iRFP-Rab5 This thesis  
mCherry-Rab5 S34N (DN) Addgene Cat#: 35139 
hSyn1-sypHy-RGECO Addgene Cat#: 84078 
Antibodies     
GFP (rabbit polyclonal, used at 1:500 in IF) Abcam Cat#: ab6556  
DeRed (rabbit polyclonal, used at 1:300 in IF) Takara Bio Clontech Cat#: 632496 
MAP2 (guinea pig polyclonal, used at 1:500 in IF) Synaptic system Cat#: 188004 
Synaptophysin (mouse monoclonal, used at 1:500 in IF)  Synaptic system Cat#: 101011 
Rab5 (mouse monoclonal, used at 1:100 in IF) Synaptic system Cat#: 108011 
CAPN1 (mouse monoclonal, used at 1:100 in IF) Thermo-FIsher Cat#: MA3-940 
CAPN2 (rabbit polyclonal, used at 1:100 in IF) Cell signaling Cat#: 2539 
CAPN2 (mouse polyclonal, used at 1:50 in IF) Santa cruz Cat#: SC-373966 
vGlut1 (guinea pig polyclonal, used at 1:500 in IF) Synaptic system Cat#: 135304 
vGAT (guinea pig polyclonal, used at 1:100 in IF) Synaptic system Cat#: 131011 
Goat anti mouse IgG Alexa Fluor 488 (used in 1:400) Thermo-FIsher Cat#: A11001 
Goat anti rabbit IgG Alexa Fluor 488 (used in 1:400) Thermo-FIsher Cat#: A11008 
Goat anti mouse IgG Alexa Fluor 568 (used in 1:400) Thermo-FIsher Cat#: A11004 
Goat anti rabbit IgG Alexa Fluor 568 (used in 1:400) Thermo-FIsher Cat#: A11011 
Goat anti mouse IgG Alexa Fluor 647 (used in 1:400) Thermo-FIsher Cat#: A21235 
Goat anti guinea pig IgG Alexa Fluor 568 (used in 1:400) Thermo-FIsher Cat#: A11075 
VPS34 (rabbit monoclonal, used at 1:250 in IB) Cell signaling Cat#: 4263S 
Synaptophysin (mouse monoclonal, used at 1:500 in IB)  Synaptic system Cat#: 101011 
Synaptotagmin1 (mouse monoclonal, used at 1:500 in IB) Synaptic system Cat#: 105011 
Clathrin heavy chain (mouse, used at 1:10 in IB) Volker Haucke Lab Custom-made 
Syntaxin 1A (mouse monoclonal, used at 1:500 in IB) Synaptic system Cat#: 110001 
SNAP25 (mouse monoclonal, used at 1:500 in IB) Synaptic system Cat#: 111011 
Dynamin (rabbit polyclonal, used at 1:500 in IB) Synaptic system Cat#: 115002 
HSP70 (mouse monoclonal, used at 1:1000 in IB) Thermo-FIsher Cat#: MA3006 
PI3K c2a (rabbit polyclonal, used at 1:100 in IB) Abcam Cat#: ab154583 
PI3K c2b (mouse monoclonal, used at 1:100 in IB) BD transduction Cat#: 611342 
Rab5 (mouse monoclonal, used at 1:200 in IB) BD transduction Cat#: 610724 
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GM130 (mouse monoclonal, used at 1:5000 in IB) Sigma-Aldrich Cat#: G8795 
cdk5 (mouse monoclonal, used at 1:250 in IB) Santa Cruz Cat#: sc6247 
p35/p25 (rabbit monoclonal, used at 1:250 in IB) Cell Signaling Cat#: 2680 
active capase3 (rabbit polyclonal, used at 1:100 in IB) Cell Signaling Cat#: 9661T 
b3-tubulin (rabbit polyclonal, used at 1:10000 in IB) Synaptic system Cat#: 302302 
GAPDH (mouse monoclonal, used at 1:5000 in IB) Sigma-Aldrich Cat#: G8795 
shRNA     
Non-target shRNA control Sigma-Aldrich SHC002 
shVPS34 Sigma-Aldrich TRCN000025373 
shVPS15 Sigma-Aldrich TRCN000027018 
shCAPN1 Sigma-Aldrich TRCN0000030664 
shCAPN2 Sigma-Aldrich TRCN0000030672 
Chemicals     
VPS34IN1 (used at 3-10 µM) MRC PPU Reagents Provided by J. Hastie  
SAR405 (used at 20-30 µM) MRC PPU Reagents Provided by J. Hastie 
ALLN (used at 100 µM) Sigma-Aldrich Cat#: A6185 
Calpeptin (used at 10 µM) Sigma-Aldrich Cat#: C8999 
Roscovitine (used at 10 µM) Sigma-Aldrich Cat#: R7772 
Cyclosporin A (used at 10 µM) Sigma-Aldrich Cat#: C3662 
Dynasore (used at 20 µM) Sigma-Aldrich Cat#: D7693 
Fluo4-AM (used at 3 µM) Thermo-FIsher Cat#: F14201 
Rapalog (used at 2 µM) Takara Bio Car#: 635056 
PI(3)P-AM (used at 20 µM) Carsten Schulz Lab Custom-made 
Xestospongin C (used at 1 µM) Sigma-Aldrich Cat#: X2628 
EGTA (used at 2 mM) Sigma-Aldrich Cat#: E3889 
EGTA-AM (used at 50 µM) Sigma-Aldrich Cat#: 324628 
AP5 (Used at (used at 20 µM) Abcam Cat#: ab120003 
CNQX (used at (used at 10 µM) Sigma-Aldrich Cat#: C127 










3.1 Regulation of excitatory neurotransmission and SV cycling by 
endosomal PI(3)P 
The exocytic fusion and endocytic reformation of synaptic vesicles from 
endosome-like vacuoles are important for sustained neurotransmission. To investigate the 
relationship between neuronal activity and endosomal trafficking in hippocampal neurons, 
we used a recombinant GFP-2x FYVE domain of EEA1 to detect PI(3)P positive endosomes 
in neuronal somata and presynaptic terminals marked by dendritic microtubules MAP2 or 
SV protein Synaptophysin, respectively. Here, we were able to detect the presence of PI(3)P 
at Synaptophysin-positive synapses which were indicated by the white arrow, and this is 
consistent with the previous finding showing the existence of PI(3)P in purified 
synaptosomes (Hoopmann et al., 2010). Interestingly, We found PI(3)P levels to be reduced 
in both somata and synapses upon sustained stimulation with trains of action potentials 
(Figure 3.1A-B). Conversely, blockage of neuronal network activity by the NMDA receptor 
antagonist AP5 or the AMPA receptor blocker CNQX induced a noticeable increase in PI(3)P 
level in somata and synapses (Figure 3.1C-D), suggesting that PI(3)P levels can be 
modulated by neuronal activity. Moreover, we tested whether PI(3)P levels are differentially 
regulated at excitatory or inhibitory synapses. Profound depletion of PI(3)P at 
vGlut1-positive excitatory synapses was observed upon train stimulation, whereas PI(3)P 
levels at vGAT-positive inhibitory synapses stayed unchanged (Figure 3.2). These data 
suggest that somatic and synaptic PI(3)P levels in excitatory neurons are inversely correlated 
with neuronal activity.  




Figure 3.1. Neuronal activity regulates endosomal PI(3)P levels.  
(A) Cultured hippocampal neurons were electrical stimulated with trains of 200APs (Stim) 
or without stimulation (-), and stained for MAP2 as somatic marker, Synatophysin (Syp) as 
synaptic marker and PI(3)P. Scale bar, 10 µm. (B) Activity induced PI(3)P reduction. 
Relative intensity of PI(3)P were quantified in somata (MAP2-positive) or synapses 
(Synaptophysin-positive) in unstimulated and stimulated neurons. Quantification were 
obtained from ≥ 60 images per condition, 5 independent experiments. (C) Cultured 
hippocampal neurons were incubated with glutamate receptor blockers, AP5 (20µM) or 
CNQX (10µM) for 24 h, and stained for MAP2, Synaptophysin and PI(3)P. Scale bar, 10 µm. 
(D) Increased PI(3)P level was in silenced neurons. Quantification were obtained from ≥ 75 
images per condition, 5 independent experiments.  
Figure 3.2. Synaptic PI(3)P levels are reduced in excitatory neurons upon stimulation. 
(A) Cultured hippocampal neurons were stimulated with 200APs and stained for PI(3)P,  
vesicular glutamate transporter 1 (vGlut1) as a marker for excitatory neuron or co-stained 
with vesicular GABA transporter (vGAT) for inhibitory neurons, Scale bar, 10 µm. (B-C) 
Relative intensity of PI(3)P in vGlut1- or vGAT-positive presynaptic terminals in 
unstimulated vs. stimulated condition. Field stimulation reduces PI(3)P levels in vGlut1- but 




Endosomal PI(3)P is mainly generated by class III PI3-kinase VPS34, which is an 
essential factor for neuronal development, spine formation, neuronal survival as well as 
preventing neurodegeneration. To study the role of PI(3)P in neurotransmission, we first 
investigated the localization of VPS34. My colleague Albert Mackintosh performed brain 
fractionation to examine the presence of Class II and Class III PI3Ks in the brain tissue. Here, 
the VPS34 was found to be co-fractionated with presynaptic proteins, Synaptotagmin and 
Synaptophysin, in crude SV fractions (Figure 3.3A). Besides, a small portion of PI(3)P can 
be synthesized by class II PI3-kinases, PI3K-C2a and PI3K-C2b, which are also found in 
SV-enriched brain fractions (Fig3.3A). Next, to manipulate PI(3)P levels in neurons, a 
selective VPS34 inhibitor, VPS34IN1 (Bago et al., 2014), was applied to hippocampal 
neurons in culture. VPS34IN1 is a highly selective and potent inhibitor of VPS34, and it 
does not significantly affect the activity of other protein kinases or class I and class II PI3K. 
Using the GFP-2XFYVE probe to detect PI(3)P, we found that somatic and synaptic PI(3)P 
were effectively depleted to nearly undetectable levels upon VPS34IN1 treatment (Figure 
3.3B-C), indicating Class III PI3-kinase VPS34 is the major enzyme that synthesizes PI(3)P 

























Figure 3.3. Presence of VPS34 in a synaptic vesicle-enriched fraction.  
(A) Subcellular fractionation of mouse brains reveals the presence of Class II (PI3KC2a, 
PI3KC2b) and Class III (VPS34) PI3Ks in the synaptic vesicle enriched LP2 fraction. H: 
total homogenate fraction, P1: crude nuclei, S1: cytoplasmic fraction, P2: crude 
synaptosomal membrane, P2’: purer synaptosomal fraction, LP1: postsynaptic membrane, 
LP2: crude presynaptic vesicles. The experiment was performed by Albert Mackintosh. (B) 
Cultured hippocampal neurons treated with VPS34IN1 (10 µM) were fixed and stained for 
MAP2, synaptophysin and PI(3)P. (C) Relative PI(3)P intensity in the MAP2-positive soma 
and in Synaptophysin-positive synaptic regions were quantified in control and 
VPS34IN1-treated neurons. A total of ≥ 35 images per condition from 3 independent 
experiments. 
 
    These findings help us to study the effects of reduced PI(3)P production on excitatory 
neurotransmission in hippocampal slices from wild-type mice. Dr. Gaga Kochlamazashvili 
performed the electrophysiological experiment. In control conditions, the field excitatory 
postsynaptic potential (fEPSP) amplitude showed normal basal neurotransmission, whereas 
pharmacological inhibition of VPS34-induced PI(3)P depletion by VPS34IN1 or SAR405, 
another selective VPS34 inhibitor (Pasquier, 2015), showed a rapid and progressive decline 
of fEPSP amplitudes (Figure 3.4A), suggesting that VPS34 inhibition causes a rundown of 
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basal excitatory neurotransmission in hippocampal neurons. A paired-pulse facilitation 
experiment was applied to test if reduced PI(3)P level affects the SV release probability. A 
facilitated second fEPSP curve means the lower initial release probability release, and it 
yields increased pair-pulse ratio when the second response is divided by the first one. Here, 
we observed that paired-pulse ratio is significantly increased in VPS34IN1-treated 
hippocampal slice (Figure 3.4C). These results indicate that VPS34 inhibition reduces the 
basal neurotransmission and the presynaptic release probability.  
 
Figure 3.4. PI(3)P depletion reduces neurotransmission and release probability. 
(A) Basal excitatory synaptic transmission of CA3-CA1 connections in acute hippocampal 
slices treated with DMSO (0.03%) or the VPS34 inhibitors, VPS34IN1 (3µM) or SAR405 
(20µM). Representative fEPSP traces (above) and the relative slope of fEPSPs (below) are 
shown. VPS34 inhibition causes a rundown of excitatory synaptic transmission. (B) 
Measurements of paired-pulse facilitation (PPF) with different interstimulus intervals (10 to 
500 ms) show no change in the slope of the second fEPSP following DMSO application 
(0.03%). (C) Increased paired-pulse facilitation (PPF) at hippocampal CA3-CA1 synapses 
after VPS34 inhibition. Representative traces of fEPSPs PPF at a 20 ms interpulse interval 
and quantification over a range of interstimulus intervals (10–500 ms), given as ratio of the 
second to the first response, show an increased facilitation of the second response in 
VPS34IN1-treated acute hippocampal slices. PI(3)P depletion causes a significant 
facilitation of the second fEPSP, indicative of reduced initial release probability. All the 
experiments shown in this figure were done by Dr. Gaga Kochlamazashvili. 
 
      To further understand the detailed mechanism underlying reduced neurotransmission 
and reduced release probability in PI(3)P-depleted hippocampal neurons, we challenged 
these results by directly probing SV exo-/ endocytosis using the reporter 
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Synaptophysin-pHluorin expressed in cultured hippocampal neurons. Synaptophysin- 
pHluorin is a pH sensitive GFP fused to the luminal domain of the SV protein Synaptophysin 
(Granseth et al., 2006). Upon action potential stimulation SVs containing 
Synaptophysin-pHluorin fuse with the presynaptic plasma membrane and get exposed to the 
neutral environment, the luminal pHluorin moiety becomes dequenched resulting in elevated 
fluorescence. This is followed by decay of the pHluorin signal as SVs are internalized via 
endocytosis and undergo vATPase-driven reacidification. Hippocampal neurons were 
transfected with a Synaptophysin-pHluorin expression plasmid at day 8 in vitro (DIV), and 
imaged at DIV14. In experiments conducted by Dr. Tolga Soykan we found reduced SV 
exocytosis in PI(3)P-depleted neurons upon 2 AP stimulation (Figure 3.5A-B). Reduced SV 
exocytosis was accompanied by a concomitant kinetic impairment of 
Synaptophysin-pHluorin endocytosis. To exclude the exocytic depression is because of 
defective SV endocytosis, we applied endocytosis inhibitor Dynasore and found that the SV 
endocytosis was not affected in response to same 2AP stimuli (Figure 3.5C). These results 
suggest that PI(3)P reduction limits excitatory neurotransmission via a signaling cascade that 
represses SV exocytosis and endocytosis by an unknown mechanism.  
 
Figure 3.5. PI(3)P depletion reduces SV exocytosis and slows SV endocytosis 
(A-C) Cultured hippocampal neuron was treated DMSO (0.1%) or VPS34IN1 (3µM) for 1h, 
and Synaptophsin-pHluorin assay was performed in imaging buffer containing 4mM 
Calcium. Surface normalized traces (A), peak responses (B) and endocytic decay constants 
(C) of Synaptophysin-pHluorin signals in response to 2 AP (10 Hz, 0.2s) stimulation. A total 
of 20 images per condition from 4 independent cultures. (D) Average traces of 
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Synaptophysin-pHluorin signals in response to 2 AP (10 Hz, 0.2s) stimulation in DIV14 
hippocampal neurons treated with Dynasore (20 µM). A total of 5 images per condition. The 
Experiments were performed by Dr. Tolga Soykan. 
 
3.2 Activity-dependent kinetic block of SV endocytosis at PI(3)P-depleted 
excitatory synapses 
     To investigate the signaling pathway underlying the effect of PI(3)P depletion on 
excitatory synaptic transmission and SV recycling, I analyzed the partitioning the 
endogenous SV protein Synaptotagmin-1 (Syt-1), an essential calcium sensor for SV cycling, 
between internal SV compartments and the cell surface at excitatory or inhibitory synapses 
upon train stimulation. Using a specific Syt-1 antibody which only recognizes the luminal 
part of the protein, to stain the surface accumulated pool of Syt-1 before puncturing of 
plasma membrane, and followed by Digitonin membrane permeabilization, the same 
antibody was used to detect total pool of Syt-1. Non-endocytosed surface accumulated 
Synaptotagmin-1 was increased in vGlut1-positive excitatory synapses (Figure 3.6A-B), but 
not vGAT-positive inhibitory synapses in VPS34IN1-treated hippocampal neurons after 
repetitive stimulation (Figure 3.6C-D), indicating that the role of PI(3)P in controlling SV 
exocytosis and endocytosis is restricted to excitatory neurons. Taken together, endosomal 
PI(3)P has a crucial physiological function in activity-dependent control of excitatory 
synaptic transmission by feedback regulation of SV exocytosis and endocytosis. These 
findings open the possibility that sustained activity may lead to depletion of PI(3)P, which in 
turn can cause rundown of excitatory transmission by reducing SV release probability and 


























Figure 3.6. Activity induces surface accumulation of Synaptotagmin-1 in excitatory 
neurons. 
(A) Cultured hippocampal neurons pre-treated with DMSO (0.1%) or VPS34IN1 (10 µM) 
were either field-stimulated with trains of 200 APs (Stim) or left unstimulated (-), fixed and 
stained for, total Synaptotagmin-1 (Syt), surface-stranded Synaptotagmin-1 and vGlut1. 
Scale bar, 10 µm. (B) VPS34-mediated PI(3)P synthesis is required for SV cycling at 
excitatory synapses (C) Cultured hippocampal neurons pre-treated with DMSO (0.1%) or 
VPS34IN1 (10µM) were either field-stimulated with trains of 200 APs (Stim) or left 
unstimulated (-), fixed and stained for surface-stranded Synaptotagmin-1, total 
Synaptotagmin-1, and vGAT. Scale bar, 10 µm. (D) VPS34-mediated PI(3)P synthesis is not 
involved in SV cycling at inhibitory synapses. A total of 40 images per condition from 3 
independent experiments. 
      
To further delineate this mechanism, we focused on the effects of PI(3)P depletion on 
SV endocytosis as a readout. Synaptophysin-pHluorin-expressing hippocampal neurons were 
stimulated with trains of 200 APs, a strong stimulation condition that can override the 
defects in release probability caused by loss of PI(3)P that was observed in brain slices and 
cultured neurons stimulated with 2 APs. Hippocampal neurons were pre-treated with 
VPS34IN1 for 1 h and stimulated with successive trains of 200 APs. The fluorescence of 
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Synaptophysin-pHluorin in individual boutons was normalized either to baseline 
fluorescence to eliminate the variations that arise from different levels of 
Synaptophysin-pHluorin expression, or to the maximum peak value during the first train to 
standardize the starting point of fluorescence decay during SV endocytosis. A progressive 
kinetic delay in SV endocytosis can be observed in PI(3)P-depleted neurons (Figure 3.7B), 
but without showing any exocytic defects (Figure 3.7A). Surface retention was plotted for 
each stimulus, displaying a profoundly increased surface accumulated pool of 
Synaptophysin-pHluorin upon VPS34IN1 treatment (Figure 3.7C), and surface accumulated 
fluorescence was built up after each stimulus. Washout of the drug (Figure 3.7D-F) by 
re-incubating neurons in inhibitor-free medium overnight or restoring PI(3)P levels by 
co-bath application of synthetic cell permeable PI(3)P (Subramanian et al., 2010) with 
VPS34IN1 reversed the defective phenotype (Figure 3.7G-I). The surface retention were 
plotted for both rescue conditions, and no surface accumulated pHluorin signal can be 
observed (Figure 3.7F and I), A similar kinetic block of SV endocytosis was further 
confirmed by another selective VPS34 inhibitor SAR405 (Figure 3.7J-L). Furthermore, we 
also used other pHluorin reporters to confirm this phenotype. Hippocampal neurons were 
transfected with either vGlut1-pHluorin (Figure 3.8D-F) or Synaptotagmin-pHluorin (Figure 
3.8G-I), and stimulated with 200AP trains. These neurons displayed similar delays in SV 
endocytosis after VPS34IN1 treatment. Stimulation of neurons with trains of 50 APs also led 
to a similar SV endocytic defect after PI(3)P depletion (Figure 3.8A-C). These data suggest 
that defects in SV endocytosis after PI(3)P depletion are independent of the stimulation 




















Figure 3.7. PI(3)P depletion blocks SV endocytosis. 
Peak normalized (A) and surface normalized (B) Synaptophysin-pHluorin responses at 
synapses of mock (DMSO)- or VPS34IN1-treated hippocampal neurons stimulated with 
consecutive trains of 200 APs. (C) PI(3)P depletion in VPS34IN1-treated neurons causes the 
progressive accumulation of Synaptophysin-pHluorin on the neuronal surface. Surface 
retention of Synaptophysin-pHluorin 90s post-stimulus is plotted for each of the four 
successive stimulation trains. A total of ≥ 40 images per condition from 6 independent 
experiments. (D-F) Overnight removal of VPS34IN1 rescues the delayed SV endocytosis. 
Peak normalized (D) and surface normalized (E) Synaptophysin-pHluorin traces at synapses 
of DMSO- or VPS34IN1- treated hippocampal neurons or overnight wash out of VPS34IN1, 
and stimulated with trains of 200APs. (F) Surface retention of Synaptophysin-pHluorin 90s 
post-stimulus is plotted for each of four repetitive stimulation trains. A total of ≥ 20 images 
per condition from 3 independent experiments. (G-I) Exogenous supply of 
membrane-permeant PI(3)P acutely rescues defective Synaptophysin-pHluorin endocytosis 
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induced by VPS34 inhibition in hippocampal neurons. Peak normalized (G) and surface 
normalized (H) pHluorin traces at synapse of different treatments, including VPS34IN1 or 
co-incubation with PI(3)P-AM (20 µM) in hippocampal neurons. A total of 15 images per 
condition from 3 independent experiments. (I) Surface retention was plotted by the same 
method described in pervious experiments. (J-L) Another VPS34 inhibitor, SAR405, 
phenocopies delayed endocytosis induced by VPS34IN1. Peak Normalized (J) and surface 
normalized (I) Synaptophysin-pHluorin traces at synapse of DMSO- or SAR405 (30 µM)- 



















Figure 3.8. Defective endocytosis can be observed in other stimulation and pHluorin 
reporter   
(A-C) Cultural hippocampal neurons were treated with VPS34IN1 (10 µM) for 1 h, and 
stimulated with four successive 50 APs (10 Hz, 5 s). Peak normalized (A) and surface 
normalized (B) Synaptophysin-pHluorin traces show the same delayed endocytosis as 200 
APs (Fig. ). (C) Surface retention of Synaptophysin-pHluorin 90s post-stimulus is plotted for 
each stimulation. A total of ≥ 11 images per condition from 3 independent experiments. (D-F) 
Cultural hippocampal neurons were transfected with vGlut1-pHluroin, treated with 
VPS34IN1 (10 µM), and stimulated with 4 x 200 APs. Peak normalized (D), surface 
normalized (E) and Surface retention (F) of vGlut-1-pHluorin signals show the defective SV 
endocytosis. A total of ≥ 15 images per condition from 3 independent experiments. (G-I) 
Cultural hippocampal neurons were transfected with Synaptotagmin1-pHluroin, treated with 
VPS34IN1 (10 µM), and stimulated with 4 x 200 APs. Peak normalized (D), surface 
normalized (E) and Surface retention (F) of Syt1-pHluorin signals show the delayed SV 
endocytosis. A total of ≥ 10 images per condition from 2 independent experiments 
54 
 
     Delayed SV endocytosis monitored by pHluorin reporters may arise either due to 
incomplete endocytosis from the plasma membrane or downstream defects in endosomal 
fusion and vesicle reacidification. To test these two hypotheses, we repeated the 
Synaptophysin-pHluorin imaging where we stimulated neurons with several trains of 200 AP 
stimulations. This time we additionally applied acidic imaging buffer to quench the surface 
Synaptophysin-pHluorin fluorescence 10 s before the first and 90 s after the last stimulation. 
The drop in fluorescence levels upon acid quenching yields a measure of the surface levels 
of Synaptophysin-pHluorin. Using this approach, we found that the Synaptophysin-pHluorin 
reporter is accumulated on the surface of the plasma membrane after repetitive stimulation in 
PI(3)P depleted neurons (Figure 3.9A), and the DF2 is larger than DF1 (Figure 3.9B), 
meaning the accumulated fluorescence are quenchable. This data indicate that loss of PI(3)P 









Figure 3.9. PI(3)P depletion cause surface accumulation of Synaptophysin-pHluorin 
signal.  
(A) Normalized Synaptophysin-pHluorin responses in cultured hippocampal neurons 
stimulated with 4 x 200 APs with 90 s intervals after 1 h pre-treatment with DMSO or 
VPS34IN1 (10 µM) and subjected to low pH image buffer before and after the stimulation 
trains. (B) The ratio of surface fluorescence of Synaptophysin-pHluorin before and after 4 x 
200 APs stimulation in DMSO- and VPS34IN1-treated neurons. A total of 15 images per 




As an alternative approach, we used a knockdown strategy to monitor the effect of 
impaired PI(3)P synthesis on SV endocytosis. Endogenous VPS34 was depleted by specific 
shRNA (shVPS34) or treated with non-targeting control shRNA (shCtrl), and stimulated with 
trains of 200 APs (Figure 3.10A-C). Upon knockdown of VPS34, akin to VPS34 inhibitors, 
SV endocytosis was impaired and a higher fraction of Synaptophysin-pHluorin remained on 
the surface after SV fusion. This finding was further supported by the knockdown of VPS15, 
an essential subunit of the VPS34 complex, which also led to delayed kinetics of SV 
endocytosis upon repetitive stimulation (Figure 3.10D-F). To confirm that the knockdown 
approach successfully depletes PI(3)P in neurons we referred to PI(3)P labeling with 
GFP-2XFYVE. As expected, PI3P levels were significantly diminished in neurons 
transfected with shVPS34 or shVPS15, also indicating an efficient blockade of VPS34 or 



















Figure 3.10. Knocking down of VPS34 subunits block synaptic vesicle endocytosis. 
(A-C) Kinetic block of Synaptophysin-pHluorin endocytosis at hippocampal synapses 
depleted of VPS34. Hippocampal neurons depleted of endogenous VPS34 by specific 
shRNA (shVPS34) or treated with non-targeting control shRNA (shCtrl), and stimulated with 
trains of 200APs. Peak normalized (A) and Surface normalized (B) of pHluorin traces at 
synapses transfected with shCtrl or shVPS34. (C) Surface retention was plotted for each 
stimulus. A total of ≥10 images per condition from 3 independent experiments. (D-F) 
Blockage of Synaptophysin-pHluroin endocytosis at hippocampal synapses depleted of 
endogenous VPS15 (shVPS15), one of subunit of VPS34 complex, or treated with non-target 
control shRNA (shCtrl). Peak normalized (D) and surface normalized (E) of pHluorin traces 
at synapses transfected with shCtrl or shVPS15. (F) Surface retention was calculated for 
each stimulus at 90s after 200APs. (G) Using GFP-2XFYVE as a probe for PI3P labeling, 
PI3P level (in green) was depleted in neurons. RFP (in red) was the indicator for successful 
transfection. The PI3P intensity of each condition was plotted in right panel which indicates 
good knockdown efficiency.   
    
To acutely manipulate PI3P levels in synaptic endosomes by another approach, an 
inducible chemically dimerization system was used together with Synaptophysin-pHluorin 
assay. The FRB-FKBP-Rapamycin heterodimer formation system is one of the most useful 
dimerization systems. Rapalog, a Rapamycin analog, binds to the 12-kDa FK506 binding 
protein (FKBP) and the FKBP-Rapamycin binding (FRB) domain, and triggers a tight 
heterodimer formation (Inobe and Nukina, 2016). The endosome-targeted FRB*-iRFP-Rab5 
construct recruits mRFP-FKBP-hMTM1 in the vicinity of the same endosome upon Rapalog 
treatment. In our experiment, hippocampal neurons were transfected with 
mRFP-FKBP-hMTM1 and FRB*-iRFP-Rab5, and treated with Rapalog or ethanol as a 
solvent control. Rapalog-induced recruitment of PI(3)-phosphatase MTM1, an enzyme 
responsible for PI(3)P dephosphorylation into PI, led to kinetic block of SV endocytosis 
(Figure 3.11A-C). Using GFP-2XFYVE as a probe for PI(3)P labeling, 
mRFP-FKBP-hMTM1 and FRB*-iRFP-Rab5 co-expressing neurons showed a great 
depletion of PI(3)P in Rapalog-treated condition (Figure 3.11D). 
















Figure 3.11. Locally depletion of endosomal PI(3)P affect synaptic vesicle endocytosis.  
Cultured hippocampal neurons were transfected with mRFP-FKBP-hMTM1 and 
FRB*-iRFP-Rab5, treated with EtOH or Rapalog, and analyzed kinetics of synaptic vesicle 
endocytosis by Synaptophysin-pHluorin. Peak normalized (A) and surface normalized (B) of 
pHluorin traces show delayed endocytosis in endosomal PI(3)P depletion boutons at trains of 
200APs. (C) Surface retention of Synaptophysin-pHluorin 90 s post-stimulus is plotted for 
each of the four successive 200 AP stimulation trains in hippocampal neurons 
expressing mRFP-FKBP-hMTM1 and FRB*-iRFP-Rab5 and treated with EtOH or Rapalog 
A total of ≥ 13 images per condition from 3 independent experiments. (D) Confocal images 
of cultured hippocampal neurons transfected with mRFP-FKBP-hMTM1 
and FRB*-iRFP-Rab5, treated with EtOH or Rapalog and stained for PI(3)P. A total of ≥ 18 
images per condition from 2 independent experiments.  
 
     Given the strong impact of neuronal activity on PI(3)P levels at excitatory synapses, 
we wondered whether the effects of VPS34IN1-induced PI(3)P depletion on SV endocytosis 
can be reversed by prior silencing of excitatory network activity. Hippocampal neurons were 
pre-incubated with NMDA receptor blocker AP5, MK801 or Na+-channel blocker 
tetrodotoxin (TTX), followed by drug washout and AP train stimulation. Pre-treatment with 
either AP5 (Figure 3.12A-C.), TTX (Figure. 3.12D-F) or MK801 (Figure 3.12G-I) prevented 
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the inhibitory effect of PI(3)P depletion by VPS34IN1 on SV endocytosis. These results thus 
reveal a critical physiological function for endosomal PI(3)P in the control of SV 
endocytosis in excitatory neurons through an activity-dependent mechanism. 
 
Figure 3.12. Impaired SV endocytosis upon VPS34IN1 treatment is activity-dependent.  
(A-C) VPS34IN1-induced defects in SV endocytosis are reverted by parallel inhibition of 
NMDA receptors by AP5 (20 µM). Peak normalized (A) and surface normalized (B) of 
Synaptophysin-pHluorin traces show normal SV endocytosis by co-incubation with AP5 and 
VPS34IN1. (C) Surface retention was plotted for each stimulation. (D-E) Defective SV 
endocytosis induced by VPS34IN1 is recovered in parallel inhibition of neuronal activity by 
TTX (200nM). Peak normalized (D) and surface normalized (E) of pHluorin signals show no 
defect upon VPS34IN1 and TTX co-treatment. (F) Surface retention was plotted for each 
stimulation. (G-I) VPS3IN1-induced defective SV endocytosis are rescued by parallel 
inhibition by another NMDA blocker, MK801 (10 µM). Peak normalized (G), surface 
normalized (H) and surface retention (I) were plotted and show the same results as (A-C). A 




3.3 Ultrastructural analysis of PI(3)P depleted synapses 
To investigate the exact mechanism how PI(3)P depletion affects SV recycling, Dr. 
Dmytro Puchkov in our lab analyzed the ultrastructure of the synapses from 
VPS34IN1-treated hippocampal neurons at rest or stimulated with trains of 200 APs by 
electron microscopy, quantitative morphometry and tomographic 3D reconstructions (Figure 
3.13). PI(3)P-depleted synapses showed a profound reduction in SV pool size and 
concomitant accumulation of endocytic invaginations which are generated from the plasma 
membrane. The number of endosome-like vacuoles (ELV), clathrin-coated pit (CCP) and 
clathrin-coated vesicles (CCV) were also increased in PI(3)P-depleted synapses compared to 
DMSO-treated control. (Figure 3.13) In the resting condition, no significant differences were 
observed in the number of SVs or other endocytic intermediates in VPS34IN1-treated 
neurons compared to control. A similar accumulation of endocytic pits and plasma 
membrane invaginations at synapses has been found in previous study using dynamin-1 or 
dynamin-1/3 knockout mice (Raimondi et al., 2011), indicating that loss of PI(3)P may 
interfere with a molecular mechanism that involves dynamin-mediated membrane fission at 
synapses.  
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Figure 3.13. Ultrastructure of PI(3)P-depleted synapses.  
(A) Examples of VPS34IN1- and DMSO-treated synapses following 4 x 200 AP stimulation. 
The postsynaptic compartment and the postsynaptic density are highlighted in green and 
purple, respectively. Note the reduced SV numbers and plasma membrane-derived endocytic 
intermediates in VPS34IN1-treated synapses. Scale bars, 500 nm (left) and 200 nm (right). 
(B) 3D-reconstruction of a synaptic terminal treated with VPS34IN1 and stimulated with 4 x 
200 APs. The plasma membrane is colored in turquoise. Synaptic vesicles (yellow), plasma 
membrane-derived invaginations (blue), endosome-like vacuoles (green) and 
clathrin-coated vesicles (red) are highlighted. Scale bar, 500 nm (top) and 200 nm (bottom). 
(C) High magnification views of endocytic intermediates accumulated in stimulated 
hippocampal neurons treated with VPS34IN1. Scale bar, 200 nm. (D-H) Morphometric 
quantification of data shown in (A-C). Synapses of VPS34IN1-treated stimulated neurons 
display reduced numbers of SVs/ bouton area (C), and an accumulation of endocytic 
membrane invaginations (D), endosome like vacuoles (F), clathrin-coated pits, CCPs (G) 
and clathrin-coated vesicles, CCVs (H). A total of 100 (SV) and 200 (invaginations, ELV, 







3.4 PI(3)P depletion blocks SV cycling by hyperactivation of Calpain2 
downstream of Rab5 
Since VPS34 and its product PI(3)P are mainly present on endosomes, and not 
directly involved in endocytic events from the plasma membrane, we hypothesized that the 
activity-dependent kinetic blockade of SV cycling when PI(3)P is depleted may result from a 
PI(3)P-dependent signaling cascade. To study its molecular mechanism, we checked the 
levels of SV proteins that may be altered upon VPS34 inhibition. Exocytic and endocytic SV 
proteins, like SNAP25, syntaxin 1A, clathrin heavy chain, heat shock protein 70 and 
dynamin, remain unchanged in VPS34IN1-treated cerebellar neuron lysates (Figure 3.14A). 
Caspase-3 levels were not changed in PI(3)P-depleted neurons, indicating that there is no 
caspase-3-dependent cell apoptosis occurred in VPS34IN1 treatment condition. Instead, we 
found a prominent change in the ratio of p35/p25 regulatory factor of the synaptic protein 
kinase Cdk5, an important enzyme for suppressing excitatory neurotransmission and release 
probability (Shah andLahiri, 2014; Tomizawa et al., 2002). p35/Cdk5 appeared to be 
proteolytically converted into hyperactive p25/Cdk5 form in PI(3)P-depleted neurons, this 
reaction is known to be catalyzed by the calcium-dependent cysteine protease Calpain (Wu 
and Lynch, 2006). Consistent with this finding, pharmacological inhibition of Calpain by 
ALLN prevented p35-to-p25 conversion (Figure 3.14B). To test if Calpain-dependent 
p35/p25 conversion is responsible for the defects in SV cycling in PI(3)P-depleted neurons, 
hippocampal neurons were treated with ALLN together with VPS34IN1. We found that SV 
endocytosis was unperturbed in PI(3)P-depleted neurons when Calpains is inactivated 
(Figure 3.14C-E). A similar rescue of VPS34IN1-induced SV endocytosis defect was 
observed when Calpains were inhibited by another calpain inhibitor Calpeptin (Figure 





Figure 3.14. PI(3)P depletion kinetically blocks SV endocytosis by Calpain activation. 
(A) Levels of various synaptic proteins in DMSO and VPS34IN1-treated cultured cerebellar 
granule neurons in culture. (B) Levels of synaptic proteins in DMSO- (0.1%) and 
VPS34IN1-(10 µM) treated cultured cerebellar granule neurons. VPS34 inhibition results in 
p35 processing to hyperactive p25, a reaction blocked by Calpain inhibitor ALLN (100 µM). 
N = 3. (C-E) Calpain inhibition by ALLN (100 µM) rescues the progressive accumulation of 
Synaptophysin-pHluorin on the neuronal surface induced by VPS34IN1. Peak normalized 
(C), surface normalized (D) of Synaptophysin-pHluorin traces, and surface retention (E) of 
each stimulus was plotted, showing the rescue phenotype. (F-H) Calpain inhibition by 
another inhibitor, Calpeptin (10 µM) reduces the accumulation of Synaptophysin-pHluorin 
on the surface induced by VPS34IN1. Peak normalized (F), surface normalized (G) of 
Synaptophysin-pHluorin traces, and surface retention (H) of each stimulus was plotted, 






There are two major Calpain isoforms expressed in the brain, Calpain1 and Calpain2, 
which play different roles in regulation of neuronal function (Huo et al., 2017). To test which 
isoform is important for PI(3)P-dependent regulation of SV endocytosis we used shRNAs 
that target either Calpain1 (Figure 3.15A-C) or Calpain2 (Figure 3.15D-F) in hippocampal 
neurons. We found that knockdown of Calpain2, but not Calpain1, prevents the 
VPS34IN1-induced inhibition of SV endocytosis, indicating that Calpain2 is the Calpain 
isoform that specifically acts downstream of PI(3)P signaling. 
 
Figure 3.15. Calpain-2 is involved in delayed SV endocytosis induced by VPS34IN1.  
(A-C) Cultured hippocampal neuron were transfected with control shRNA (shCtrl) or 
shRNA against calpain-1 (shCAPN1) and treated with DMSO or VPS34IN1. Peak 
normalized (A) and surface normalized (B) of Synaptophysin-pHluorin traces show that 
knockdown of Calpain doesn’t rescue defective SV endocytosis induced by VPS34IN1. (C) 
Surface retention of Synaptophysin-pHluorin 90 s post-stimulus is plotted for each of the 
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four successive stimulation trains in shCtrl or shCAPN1 transfected neurons treated 
with DMSO or VPS34IN1 (10 µM). A total of ≥ 10 images per condition from 3 independent 
experiments. (D-F) Cultured hippocampal neuron were transfected with control shRNA 
(shCtrl) or shRNA against calpain-2 (shCAPN2) and treated with DMSO or VPS34IN1. 
Peak normalized (D) and surface normalized (E) of Synaptophysin-pHluorin traces show 
that knockdown of Calpain rescues defective SV endocytosis induced by VPS34IN1. (F) 
Surface retention of Synaptophysin-pHluorin 90 s post-stimulus is plotted for each of the 
four successive stimulation trains in shCtrl or shCAPN2 transfected neurons treated 
with DMSO or VPS34IN1 (10 µM). A total of ≥ 11 images per condition from 3 independent 
experiments. (G-H) immunostaining of Calapin-1 or -2 show successful knockdown in 
neurons.    
  
Calpain activation is triggered by calcium influx. Therefore, we tested whether 
calcium was elevated in neurons treated with VPS34IN1. Hippocampal neurons were treated 
with VPS34IN1 and stained with the basal calcium indicator Fluo-4 (Figure 3.16A). PI(3)P 
depleted neurons displayed 40% elevation of basal calcium in their somata. To measure the 
calcium level at synapses, we used a recombinant plasmid that bears an additional 
red-shifted calcium sensor, RGECO, fused to the cytoplasmic domain of 
Synaptophysin-pHluorin (Jackson and Burrone, 2016). The basal RGECO signal at synapses 
was 30% higher in VPS34IN1-treated synapses (Figure 3.16B), indicating that calcium 
levels were also elevated at synapses after PI(3)P depletion. To determine the source of 
calcium, we used membrane-impermeable and permeable calcium chelators EGTA and 
EGTA-AM, as well as Xestospongin C, a blocker for IP3-dependent calcium efflux from the 
endoplasmic reticulum (ER). We found that EGTA, the extracellular calcium chelator, can 
rescue impaired SV endocytosis induced by PI(3)P depletion (Figure 3.16C-E). Using a 
cell-permeable version of EGTA, EGTA-AM, to chelate the intracellular calcium, the 
increased surface retention of Synaptophysin-pHluorin induced by VPS34 inhibition was 
also rescued (Figure 3.16F-H). In contrast, blocking calcium efflux from the ER by 
Xestospongin C did not rescue defective SV endocytosis induced by VPS34IN1 (Figure 
3.16I-K.). These data suggest that elevation in the concentration of intracellular calcium in 
PI(3)P-depleted neurons is mainly caused by calcium influx from the cell exterior. 
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Furthermore, we wondered if we can mimic the defective SV endocytosis by creating a high 
intracellular calcium environment by using Ionomycin to permeabilize the plasma membrane 
to allow for excessive calcium influx. Even though ionomycin treatment, similar to 
PI(3)P-depletion, caused an elevation in the intracellular calcium concentration, these 
neurons did not display a similar SV endocytosis defect (Figure 3.17). Taken together, these 
data indicated that even though elevated intracellular calcium plays a role in the SV 





Figure 3.16. Calcium is required for calpain activation and contributes to the SV 
endocytosis defect. 
(A) Cultured hippocampal neurons were treated by DMSO or VPS34IN1 (10 µM), and 
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moved to the medium containing calcium indicator, Fluo-4 (3 µM) and Pluronic F-127. 
Basal calcium level is detected by Fluo-4, and show 40% increase upon VPS34 inhibition. 
(B) Cultured hippocampal neurons were transfected with SypHy-RGECO and treated with 
DMSO or VPS34IN1 (10 µM). Synaptic calcium level is measured by RGECO signal. (C-E) 
Extracellular calcium chelation by EGTA (2mM) reverts the defective SV endocytosis. Peak 
normalized (C) and surface normalized of Synaptophysin-pHluorin traces reveal the normal 
SV endocytosis upon co-incubation of VPS34IN1 and EGTA. (E) Surface retention of 
Synaptophysin-pHluorin 90 s post-stimulus is plotted for each of the four successive 
stimulation trains. A total of ≥ 15 images per condition from 3 independent experiments. 
(F-H) Intracellular calcium chelation by cell permeable EGTA-AM (50 µM) revert the 
defective SV endocytosis. Peak normalized (F) and surface normalized (G) of 
Synaptophysin-pHluorin traces reveal the normal SV endocytosis upon co-incubation of 
VPS34IN1 and EGTA-AM. (H) Surface retention of Synaptophysin-pHluorin 90 s 
post-stimulus is plotted for each of the four successive stimulation trains. A total of ≥ 10 
images per condition from 3 independent experiments. (I-K) Hippocampal neurons were 
treated with DMSO or VPS34IN1 (10 µM) together with or without Xestospongin C (XeC, 1 
µM) to block calcium release from ER. Peak normalized (I) and surface normalized (J) of 
Synaptophysin-pHluorin traces show defective SV endocytosis upon co-incubation of 
VPS34IN1 and XeC. (H) Surface retention of Synaptophysin-pHluorin 90 s post-stimulus is 
plotted for each of the four successive stimulation trains. A total of ≥ 12 images per 
condition from 3 independent experiments. 
 
 
Figure 3.17. Increasing intracellular calcium is not the key factor for delayed SV 
endocytosis induced by VPS34IN1. 
(A-B) Cultured hippocampal neurons were treated with Ionomysin (4 µM) and CaCl2 (2 mM 
or 5 mM) for 3 h. Peak normalized (A) and surface normalized (B) of 
Synaptophysin-pHluorin traces do not show any obvious defective SV endocytosis. A total 
of ≥ 12 images per condition from 2 independent experiments. (C) Cultured hippocampal 
neurons were treated by DMSO, VPS34IN1 (10 µM), Ionomycin (4 µM) and CaCl2, and 
moved to the medium containing calcium indicator, Fluo-4 (3 µM) and Pluronic F-127. 
Basal calcium level is detected by Fluo-4, and show 40% increase upon VPS34IN1 or 





A previous study in non-neuronal cells has established that Calpain2 activity requires 
its recruitment to early endosomes by interacting with endosomal protein EEA1 and the 
small GTPase Rab5 (Mendoza et al., 2018). In parallel, loss of VPS34 has been found to 
cause Rab5 accumulation and hyperactivation (Bechtel et al., 2013). Therefore, we 
hypothesized that VPS34IN1-induced PI(3)P depletion may cause Calpain2 activation due to 
the accumulation of hyperactive Rab5 on endosomes. First, we confirmed the previous 
findings by Rab5 and Calpain2 coimmunostaining. We found that PI(3)P depletion led to 
enhanced accumulation of Rab5 in somatic and synaptic structures. These Rab5 
accumulations most probably highlight enlarged endosomes, which are often positive for 
Calpain2 (Figure 3.18A-C), suggesting a correlation between PI(3)P, Rab5 and Calpain2. We 
propose that PI(3)P depletion upon VPS34 inhibition causes Calpain2 activation via its 
recruitment to enlarged endosomes. The precise mechanism of this recruitment process 
remains to be identified. 
Next, we tested whether blockade of Rab5 activity can rescue VPS34IN1-induced SV 
endocytosis defect. Hippocampal neurons were transfected with either the dominant negative 
(DN) and constitutively active (CA) mutants of Rab5-mCherry (Figure 3.18D-I), and treated 
with VPS34IN1. Rab5 DN overexpression occluded the inhibition of SV endocytosis by 
VPS34 inhibition, while Rab5 CA had no impact. These findings thus indicate that PI(3)P 
depleted neurons may initiate a signaling pathway that enhances Rab5 activation, which then 




Figure 3.18. Rab5 is upstream of calpain-2 activation induced by PI(3)P depletion.  
(A-B) VPS34IN1 treatment leads to increased levels of distinctive Rab5 puncta in neuronal 
somata and in vGLUT1-positive excitatory synapses. (C) Calpain-2 is localized to these 
Rab5-containing puncta, but there is no obvious accumulation of calpain-2. A total of 50 
images per condition from 3 independent experiments. (D-F) Overexpression of dominant 
negative Rab5 (Rab5-DN) rescues the progressive accumulation of Synaptophysin-pHluorin 
on the surface in VPS34IN1-treated hippocampal. Peak normalized (D) and surface 
normalized (E) of Synaptophysin-pHluorin signals show delayed SV endocytosis upon 
VPS34 inhibition. (F) Surface retention is plotted for each stimulus and is slightly increased 
at the fourth stimulus in VPS34IN1- treated neurons. (G-I) Overexpression of constitutively 
active Rab5 (Rab5-CA) do not rescue progressive accumulation of Synaptophysin-pHluorin 
on the surface of VPS34IN1-treated hippocampal neurons is analyzed. A total of ≥ 10 images 










Figure 3.19. Signaling pathway for Cdk5 
hyperactivation. 
Hypothetical signaling pathway for the induction of 
hyperactive Cdk5 induced by repression of VPS34 




     Previous studies have shown that Cdk5 hyperactivation reduces presynaptic release 
probability (Kim and Ryan, 2010). If hyperactivation of Cdk5 underlies the defective 
excitatory synaptic transmission in VPS34IN1-treated neurons, repression of its activity 
should rescue impaired SV endocytosis and glutamatergic neurotransmitter release. To 
further understand the role of Cdk5 in neurotransmission and SV cycling, we treated 
hippocampal neurons with the Cdk5 inhibitor Roscovitine together with VPS34IN1 (Figure 
3.20A-C). Cdk5 inhibition perfectly rescued the VP34IN1-induced SV endocytosis defect in 
response to repetitive stimulation. These results show that neuronal activity-induced PI(3)P 
depletion leads to Cdk5 hyperactivation which may control SV exo-/endocytosis in 
excitatory neurotransmission. Dr. Gaga Kochlamazashvili tested this hypothesis in acute 
slice preparation of hippocampal neurons, we found that Cdk5 inhibition also completely 
occluded the adverse effects of pharmacological inhibition of VPS34-mediated PI(3)P 
synthesis on excitatory neurotransmission (Figure 3.20D). Besides, Roscovitine reverted the 
increased paired pulse ratio induced by VPS34IN1, and instead led to a lower paired pulse 
ratio, an indication of elevated release probability (Figure 3.20E). Based on these findings, 
we conclude that PI(3)P depletion leads to Calpain2-mediated Cdk5 hyperactivation, which 







Figure 3.20. Cdk5 inhibition rescues defective SV endocytosis and neurotransmission 
induced by PI(3)P depletion. 
(A-C) Cdk5 inhibition by Roscovitine (10 µM) rescues the progressive accumulation of 
Synaptophysin-pHluorin on the neuronal surface induced by VPS34IN1. Peak normalized (A) 
and surface normalized (B) of Synaptophysin-pHluorin traces show normal SV endocytosis 
in Roscovitine and VPS34IN1 co-treated neurons. (C)Surface retention of 
Synaptophysin-pHluorin 90 s post-stimulus is plotted for each of the four successive 
stimulation trains. A total of 20 images per condition from 4 independent experiments. 
(D) Basal excitatory synaptic transmission of CA3-CA1 connections in acute hippocampal 
slices treated with DMSO (0.03%) or VPS34IN1 plus Roscovitine. Representative fEPSP 
traces (above) and the relative slope of fEPSPs (below) are shown. Concomitant application 
of VPS34IN1 and Roscovitine facilitates excitatory synaptic transmission, akin to 
Roscovitine alone(E). (E) Decreased paired paired-pulse facilitation (PPF) at hippocampal 
CA3-CA1 synapses treated with VPS34IN1 plus Roscovitine. Representative traces of 
fEPSPs PPF at a 20-ms interpulse interval and quantification over a range of interpulse 
intervals (10–500 ms) given as ratio of the second to the first response. The data show 
decreased facilitation of the second response in VPS34IN1- plus Roscovitine-treated acute 
hippocampal slices. Electrophysiology experiments were done by Dr. Gaga 
Kochlamazashvili (D-G).  
 
      The balanced activity of the phosphatase Calcineurin and the kinase Cdk5 is known 
to set the release probability in neurons, and Calcineurin is known to counteract Cdk5 by 
dephosphorylating Cdk5 substrates (Kumashiro et al., 2005; Shah andLahiri, 2014). Given 
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that Cdk5 inhibition fully rescues PI(3)P depletion-indued SV endocytosis impairment, we 
wondered whether application of Calcineurin inhibitor Cyclosporin A would phenocopy 
VPS34IN1-induced defective SV endocytosis. Synaptophysin-pHluroin-expressing 
hippocampal neurons were treated with Cyclosporin A and stimulated with 200 AP trains 
(Figure 3.21). Effects of VPS34IN1 on the kinetics of SV endocytosis in response to trains 
stimulation were mimicked by Cyclosporin A treatment. These results confirm that neuronal 
PI(3)P is capable of regulating SV recycling and neurotransmission via modulating the  








Figure 3.21. Calcineurin inhibition induced defective SV endocytosis. 
(A-C) Calcineurin inhibition by Cyclosporin A (10 µM) phenocopies VPS34IN1-induced 
loss of PI(3)P with respect to the accumulation of Synaptophysin-pHluorin on the neuronal 
surface. Peak normalized (A) and surface normalized (B) of pHluorin signals were analyzed. 
(C) Surface retention of Synaptophysin-pHluorin 90 s post-stimulus is plotted for each of the 
four successive stimulation trains. A total of ≥ 15 images per condition from 3 independent 
experiments 
 
3.5 The regulatory role of PI(3)P in neuronal network activity           
Depressed excitatory neurotransmission induced by activity-dependent PI(3)P 
reduction may be important for controlling and restricting neuronal network activity (Marder 
and Goaillard, 2006; Nelson and Valakh, 2015). To investigate whether loss of PI(3)P 
restricts excitatory neurotransmission when inhibitory network is impaired, we disinhibited 
hippocampal neurons and measured polyspiking as an indication for neuronal excitability. 
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We found that activity-dependent disinhibition induced by 1 Hz stimulation within the 
hippocampal network resulted facilitation of PSs and a profound repression of polyspiking 
activity in VPS34IN1-treated slices, while Roscovitine caused the opposite phenotype 
(Figure 3.22A-B), suggesting that PI(3)P depletion restricts neuronal network activity by 
repressing excitatory transmission. To further confirm our findings, we applied GABAA 
receptor antagonist Picrotoxin to block inhibitory transmission, and then induce polyspike 
waves. PI(3)P depletion potently repressed the Picrotoxin-induced strong polyspilking 
activity, suggesting endosomal PI(3)P depletion restricts neuronal activity (Figure 3.22C-D). 
These results thus elucidate a crucial unknown function for endosomal phospholipid PI(3)P 













Figure 3.22. PI(3)P regulates neuronal network activity.  
(A-B) Activity-dependent polyspiking of population spikes (PS) during 1 Hz stimulation is 
reduced by VPS34IN1 and facilitated by Roscovitine compared to DMSO-treated control 
slices. Top, representative traces of the 1st and 30th stimulus responses with polyspikes 
indicated by arrows. (C-D) PS and polyspike areas in the presence of picrotoxin (50 µM) 




       In addition to being a target of a signaling cascade that starts by PI(3)P depletion, 
Cdk5 also negatively regulates VPS34-mediated PI(3)P synthesis (Furuya et al., 2010). To 
investigate the role of Cdk5 and Calapin in activity-dependent PI(3)P loss, we measured 
PI(3)P levels in Cdk5 or Calpain inhibitor-treated neurons upon repetitive stimulation. We 
found that loss of Cdk5 and Calpain activity prevented the activity-induced PI(3)P depletion 
on endosomes in hippocampal neurons (Figure 3.23). Thus, we propose that the endosomal 
VPS34, Calpain and Cdk5 are part of the same autoregulated signaling cascade that scales 
excitatory neurotransmission in neuronal network.   
 
Figure 3.23. Cdk5 and Calpain inhibition restore the activity-induced PI(3)P depletion.  
(A, C) Cultured hippocampal neurons treated with Roscovitine (10 µM) or ALLN (100 µM), 
stimulated with 4 x 200 APs, fixed and stained for MAP2, Synaptophysin and PI(3)P. Scale 
bar, 10 µm. (B, D) Treatment with Roscovitine and ALLN prevents the stimulation-induced 
depletion of PI(3)P in MAP2-positive somata and Synaptophysin-positive synaptic regions. 




Our findings identify a novel autoregulatory pathway for the cell-intrinsic control of 
excitatory neurotransmission and vesicle cycling by the endosomal PI(3)P that acts 
independently and in parallel to inhibitory synaptic input. Activity-induced repression of 
VPS34-mediated PI(3)P synthesis on endosome is shown to trigger the calcium- and 
Calpain2-mediated Cdk5 activation, resulting in impaired SV exo-/ endocytosis and reduced 
SV release to repress excitatory neurotransmission (Figure 3.24). 
 
Figure 3.24. A working-model for the feedback regulation of excitatory synaptic activity. 
Neuronal activity downregulates VSP34-mediated synthesis of endosomal PI(3)P. PI(3)P 
depletion causes the activation of Calpain-2 and Cdk5 resulting in the repression of 














4. Discussion  
      In this thesis, I have identified a novel feedback regulation mechanism that 
cell-intrinsically controls excitatory neurotransmission and vesicle recycling that operates 
through endosomal PI(3)P. Neuronal activity-induced activation of Cdk5 reduces PI(3)P 
synthesis by VPS34, and thereby triggers Rab5 and Calpain2 activation. p35-p25 conversion 
induced by elevated intracellular calcium and Calpain2-mediated cleavage leads to Cdk5 
activation. The activity-dependent depletion of PI(3)P synthesized by VPS34 and depression 
of excitatory neurotransmission were occluded by pharmacological blockade of Cdk5 
activity. These results unravel an unexpected and novel function for endosomal PI(3)P at 
synapses in SV cycling, scaling excitatory neurotransmission and stabilizing network activity, 
and this mechanism may explain the involvement of VPS34 in neurodevelopmental disease 
and neurodegeneration. 
 
4.1 The role of phosphoinositides in synaptic function 
Phosphoinositides are specifically localized to organelle membranes and regulate 
neuronal function by recruiting several phosphoinositide-binding proteins. The most 
well-studied phosphoinositide at the synapses is PI(4,5)P2 that is mainly produced on the 
plasma membrane (Fon andEdwards, 2001). PI(4,5)P2 is an important lipid component for 
SV priming, Ca2+-triggered SV exocytosis and SV endocytosis by recruitung different SV 
proteins which contain PI(4,5)P2-binding domain (Okamoto and Südhof, 1997; Saheki and 
DeCamilli, 2012; Südhof, 2012). One the other hand, the endosomal PI(3)P is considered to 
be involved in endosomal protein or membrane trafficking. Surprisingly, we found that the 
delayed SV endocytosis upon PI(3)P-depletion is due to incomplete endocytic uptake of SVs 
from the plasma membrane (Figure 3.9), suggesting that the endosomal PI(3)P has a novel 
function in SV recycling.  
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Additionally, phosphoinositides have been implicated in regulating synaptic plasticity. 
PI(3,4,5)P3 synthesis by class I PI3K in crucial for maintaining AMPA receptor clustering 
(Arendt et al., 2010), and consequently modulates the synaptic plasticity. PI(3,5)P2 is also 
involved in the trafficking of AMPA receptor to the plasma membrane on the postsynaptic 
site (Seebohm et al., 2012). In our study, we focused on the potential role of endosomal 
PI(3)P in SV recycling and neurotransmission, primarily focusing on the presynaptic 
terminal.    
 
4.2 The PI(3)P/Calpain2/Cdk5 pathway  
      Calpains are intracellular Ca2+-dependent proteases that play roles in diverse 
biological mechanism through limited proteolysis of their substrates. Calpain1 and Calpain2 
are two major calpains expressed in the central nervous system and they are both localized at 
synapses. Calpains have many synaptic substrates such as NMDA receptor, AMPA receptor, 
postsynaptic density proteins, Dynamin, kinases and phosphatases, which are all involved in 
various steps of synaptic function. In vitro studies have shown that excess glutamate and 
Ab-induced cleavage of NR2A and NR2B subunits of NMDA receptors happens via Calpain 
activation, which in turn downregulates NMDA receptor levels and prevents pathological 
process. Also, synaptic architecture proteins spectrin and MAP2 are substrates of Calpain for 
regulation of synaptic integrity and stability (Wu and Lynch, 2006). In our study, we have 
shown that PI3P depletion leads to Calpain activation at the synapse. Dynamin, which is one 
of the targets of Calpain, is also partially cleaved in VPS34IN1-treated cerebellar granule 
neurons (Figure 3.14A). This observation has raised the possibility that the impairments in 
SV recycling after PI(3)P depletion is due to dynamin cleavage. However, we have also 
made a number of observations that has invalidated this possibility: 1) Dynamin cleavage 
has not been observed in hippocampal cultures, which has been the major experimental 
model throughout this study. This may be due to differences of the culture conditions 
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between hippocampal and cerebellar cultures. The cerebellar neurons are cultured in the 
KCl-containing medium with high levels of baseline activity, whereas hippocampal neurons 
are maintained in conditions with limited network activity. 2) Inhibition of Cdk5, which is 
activated downstream of Calpains, did not rescue Dynamin cleavage in cerebellar neurons, 
even though it fully rescued VPS34IN1-induced SV endocytosis defect in hippocampal 
neurons. 3) Elevation of intracellular Ca2+ via ionomycin treatment had no effect on SV 
endocytosis, suggesting that elevated intracellular calcium concentration and Calpain are not 
the sole trigger for delayed endocytosis. Thus, we propose that Calpain activation does not 
directly target synaptic proteins involved in SV recycling, but rather utilizes an indirect 
feedback regulation through Cdk5 to modulate SV recycling and neurotransmission.   
      Interestingly, Cdk5 has been proposed to negatively regulate VPS34 activity via 
phosphorylation of VPS34 which leads to instability of the VPS34 complex (Furuya et al., 
2010). Consistent with our hypothesis, pharmacological inhibition of Cdk5 and Calpain 
restore the activity-dependent PI(3)P depletion in hippocampal neurons (Figure 3.23), 
suggesting the presence of an autoregulatory signaling pathway between Cdk5, 
VPS34-mediated PI(3)P synthesis and Calpain2 (Figure 3.19) that scales excitatory 
neurotransmission. The phosphorylation site of VPS34 by Cdk5 has been identified. By 
generating phosphomimetic or phosphodeficient mutants of VPS34 it will be possible to 
directly study the physiological relevance of activity-dependent regulation of VPS34 via 
Cdk5 on neurotransmission and synaptic scaling. 
 
4.3 The role of endosomal PI(3)P in neurotransmission 
       The VPS34 complex and its product PI(3)P play crucial roles in several cellular 
mechanisms. Even though the role of VPS34 in autophagy or intracellular protein trafficking 
in non-neuronal cells has been well studied, the role of PI(3)P in neurotransmission is poorly 
understood. During SV recycling, the endocytic vesicles are usually delivered to 
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endosome-like structures that have been proposed to be the major sorting platform for SV 
protein recycling or degradation. In our study, we have identified the presence of VPS34 in 
crude SV fraction, and proposed a novel function of endosomal PI(3)P in scaling excitatory 
neurotransmission by regulating SV cycling. SV exo- and endocytosis were severely 
impaired in the absence of VPS34 activity. The defects in SV exocytosis is not a direct 
consequence of dysfunctional SV endocytosis. Interestingly, the defects in SV exocytosis is 
severe only when neurons were stimulated by few AP stimulation, and no longer detectable 
under sustained stimulation condition. It is possible that the responded synaptic boutons we 
have detected upon 2 AP stimulation may differ to the one responded to strong and sustained 
stimulation. All the SVs at synapse are accessible upon 200APs stimulation and this strong 
saturation may bring SV release close to saturation, which may have concealed the effect of 
PI(3)P loss on SV release. 
Acute inhibition of Cdk5 completely rescues defects in SV endocytosis during trains 
of APs in the near absence of PI(3)P, indicating that PI(3)P-containing endosomes are largely 
dispensable for SV cycling, contrary to the prior proposal (Hoopmann et al., 2010), where 
SVs were proposed to pass through an early endosomal compartment. In this study, we 
propose an alternative role for PI(3)P-positive endosomes. Instead of actively participating in 
the direct path that SVs use during their recycling, PI(3)P-positive endosomes respond to 
neuronal excitation and lose their PI(3)P, which eventually leads to Cdk5 activation for 
scaling down of neurotransmission. In the absence of neuronal activity, PI(3)P levels rise, 
maintaining Cdk5 in an inactive state which increases SV release probability and thus 
neuronal excitability through neurotransmitter release (Figure 4.1). Thus, we hypothesize 
that PI(3)P-containing neuronal endosome acts as a master checkpoint for cell-intrinsic 





Figure 4.1. Hypothical model of PI(3)P serve as a checkpoint for neurotransmission. 
PI(3)P downregulation by chronic excitation and upregulation by chronic inhibition affect 
Cdk5 activity and its function in synaptic vesicle recycling and transmitter release. (Drew by 
Dr. Tolga Soykan)  
 
4.4 The role of VPS34 complexes in other neuronal function  
VPS34 complex II is important for various intracellular trafficking routes and it is the 
major enzyme to produce PI(3)P on endosomes. Here we blocked PI(3)P synthesis with 
different approaches, including pharmacological inhibition, Rapalog-induced dimerization 
system as well as gene knockdown. Direct inhibition of VPS34 complex activity via VPS34 
knockdown or indirect inhibition via VPS15 knockdown showed successful depletion of 
P(3)P at somata and synapses. However, we cannot distinguish the contribution of VPS34 
complex I and complex II using these approaches. To study which of the two complexes is 
primarily involved in the neurotransmission, a specific targeting method is required. We tried 
to knockdown UVRAG, a subunit of VPS34 complex II, but the commercially available 
UVRAG shRNA is not sufficient to deplete VPS34 activity (data not shown). Thus another 
approach for efficiently targeting UVRAG or ATG14 are required. Interestingly, UVRAG 
and ATG14 have VPS34-independent functions in endocytic trafficking. UVRAG binds to 
homotypic fusion and vacuole protein sorting (HOPS) complex, and acts as a Rab7 effector 
to trigger endosomal membrane fusion events (Balderhaar and Ungermann, 2013). Also, 
ATG14 interacts with SNAREs and associated proteins to mediate endosomal fusion (Diao 
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et al., 2015). The endocytic fusion defects affect the protein homeostasis and 
endosomal-lysosomal system in the cells. The VPS34 inhibition-induced complex instability 
may release more subunits form the complex, and affect other cellular functions. 
Furthermore, the activity of VPS34 complex is tightly regulated. The 
posttranslational modification of VPS34 complex I and II subunits has been studied in 
various systems For example, phosphorylation of VPS34 subunit by Cdk5 inhibits the kinase 
activity and PI(3)P synthesis (Tsai et al., 2010), and mTOR phosphorylates Beclin1 or 
UVRAG to inhibit the complex activity and prevent induction of autophagy (Gulati et al., 
2008). All these modifications of VPS34 complexes contribute to the regulation of their 
functions, and consequently play different roles in several cellular mechanisms. Besides, 
VPS34 is a positive regulator of Phosphatase and tensin homolog (PTEN) (Naguib et al., 
2015), and hence a negative regulator of class I PI3K signaling. It is suggested that there is a 
potential crosstalk between VPS34 and other signaling pathways. In my thesis, I manipulated 
the PI(3)P synthesis through different approaches, including pharmacological treatment or 
knockdown of VPS34/VPS15, to validate the essential role of PI(3)P synthesis by VPS34 in 
SV recycling. However, we cannot exclude that inhibition of VPS34 may interfere with the 
function of other subunits, contribute to imbalanced signaling cascade, and finally cause 
defects in neuronal function. In this study, we also concluded that PI(3)P synthesis by VPS34 
is required for SV endocytosis. The role of VPS34 in endocytosis is supported by a study 
based on Beclin1-deficient mice. It reported that loss of Beclin1 leads to PI(3)P 
mislocalization, abnormal endosome formation and severe neurodegeneration in cerebellar 
Purkinje cells and hippocampal neurons. Beclin1-deficient mammalian cells display reduced 
PI(3)P level and impaired EGFR endocytosis. The endocytic defects is due to disruption of 
Rab5-dependent endosome formation, suggesting that Beclin1 is required for VPS34 
complex-mediated endocytosis (McKnight et al., 2014). Therefore, VPS34-mediated PI(3)P 
synthesis is a key regulator for endocytic events and endosome formation.  
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In addition to its role in endocytosis, a PI(3)P-binding protein Ankyrin is required for  
synaptic vesicles trafficking along microtubules. The dynactin complex, an adaptor for 
dynein-mediated retrograde transport, is crucial for vesicle transport through PI(3)P binding 
Ankyrin adaptor, and the axonal transport is disrupted in VPS34 depleted hippocampal 
neurons (Lorenzo et al., 2014). It is likely that the VPS34 inactivation-induced PI(3)P 
depletion not only impairs the SV cycling at the synapses, but also affects the retrograde 
transport along the axon. However, the detailed mechanism of how VPS34 complex 
regulates axonal retrograde transport requires further investigation. 
 
4.5 The role of VPS34 and autophagy in neurons 
Inhibition of VPS34 not only impairs the endosomal trafficking, but also reduces 
autophagy. However, the autophagy pathway is complex, and it is triggered by multiple steps 
and numerous regulators. The roles of autophagy in neuron has been addressed in several 
studies. For example, Beclin1-deficient murine embryonic fibroblasts showed decreased 
autophagy and endosomal trafficking, and loss of Beclin1 results in severe 
neurodegeneration (McKnight et al., 2014). The defective protein clearance induced by 
block of autophagy is implicated in several neurodegenerative diseases. In addition to the its 
role in pathological conditions, autophagy is required for synaptic function and 
neurotransmission (Figure 1.6) (Lieberman andSulzer, 2020). Intriguingly, using KCl to 
depolarize rat hippocampal neurons, transiently increased number of autophagosomes and 
enhanced autophagic degradation of AMPA receptors were observed, while these phenotypes 
were partially restored by AP5 or NMDA receptor blocker. suggesting that autophagy 
contributes to NMDA receptor- dependent synaptic plasticity (Shehata et al., 2012). 
The role of VPS34 complexes in endosomal and autphagosomal pathways are deeply 
interconnected. It is crucial to understand the relationship between these pathways system in 
neurons. The experimental perturbations of VPS34 activity that impair SV endocytosis may 
82 
 
either arise from disruptions in either the endosomal trafficking or autophagy (Itakura et al., 
2009). Thus, more comprehensive experiments based on specific targeting of individual 
VPS34 complexes are needed for elucidating the precise role of each VPS34 complex in 
neurotransmission. 
 
4.6 The link between PI(3)P and Calpain 
A previous study has shown that Calpains are recruited to early endosomes in a 
Rab5-dependent manner in non-neuronal cells (Mendoza et al., 2018). We also had a similar 
observation in our study showing that PI(3)P depletion-induced accumulation of Rab5 in the 
neuronal cell body and synapses where Calpain2 is recruited to (Figure 3.18). Interestingly, 
the Calpain activation is not merely dependent on Rab5 activity, given that the constitutively 
active Rab5-overexpressing neurons, did not exhibit similar levels of SV endocytosis defects 
as in VPS34IN1-treated neurons (Figure 3.18G-I). This suggests that Rab5 accumulation is 
necessary but not sufficient for triggering Calpain activation. Due to the complex function of 
VPS34, it is possible that other factors are involved in this pathway and it requires for further 
investigation.  
Besides, we did not detect significantly increased Calpain2 signal at the soma and 
synapse (Figure 3.18C). The possible explanations may be due to the change of Calpain 
activity itself instead of its protein level. Alternatively the association between endogenous 
inhibitor Calpastatin and Calpain may change with PI(3)P reduction. A study have shown 
that viral transduction of Calpastatin in cortical neurons resulted in localization of 
Calpastatin to endosomal structures (Sengoku et al., 2004) which is then crucial for 
regulating the Calpain activity. VPS34 inhibition which causes abnormal endocytic function 





4.7 Dysregulation of PI(3)P and Cdk5 in diseases 
      Dysfunctional intracellular protein trafficking and autophagy by VPS34 inactivation 
has been implicated in several neurodevelopmental diseases, neurodegenerative diseases, or 
mood disorders. In patients or mice with Alzheimer’s disease (AD), PI(3)P is the only 
phosphoinositide which is selectively decreased in the brain tissue, and inhibition of VPS34 
causes an enlargement of neuronal endosomes which then enhances the amyloidogenic 
processing of APP (Morel et al., 2013b). Multiple studied suggested that the Calpain 
activation-induced Cdk5 hyperactivation is a key pathological pathway for forming 
neurofibrillary tangles which is a feature for AD diagnosis. Here we propose that the 
Calpain/p25/Cdk5 pathway is directly linked to the VPS34 activity and PI(3)P levels and 
these two pathways can reciprocally control each other to modulate neurotransmission.  
      Additionally, VPS34 was proposed to be involved in pathogenesis of schizophrenia 
and bipolar disorder, and mutations in VPS34 are linked to increase the susceptibility to both 
mood disorders (Stopkova et al., 2004). Lithium is a widely used treatment for mood 
disorders, and it has effects on phosphoinositide pathway and synaptic scaling, suggesting 
the phosphoinositide metabolism and impaired synaptic plasticity could underlie the 
susceptibility of schizophrenia (Kavalali and Monteggia, 2020; Stopkova et al., 2004). We 
proposed that the endosomal VPS34-Cdk5 pathway plays a complementary role to 
homeostatic scaling, a mechanism for up- or downregulating synaptic weights under certain 
conditions. While we focus on the excitatory neurotransmission in hippocampus, we 
speculate that the basic principles of autoregulatory PI(3)P-Cdk5 pathway are conserved in 
other networks, such as cortex or cerebellum. To summarize, our findings are consistent with 
the possible involvement of PI(3)P in different neurological diseases, for instance, 
neurodevelopmental disease characterized by imbalance of excitatory/ inhibitory 
transmission (Nelson and Valakh, 2015), and in neurodegenerative disease. Therefore, 
pharmacological targeting of endosomal PI(3)P synthesis and turnover may become a 
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potential treatment of these diseases and other neurological disorders associated with 
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6.1 Appendix A: Abbreviations 
 
Ach Acetylcholine 
AD Activity-dependent bulk endocytosis 
ADBE Alzheimer’s disease 
AMPA α-amino-3-hydroxy-5- methyl-4-isoxazole-propionic acid 
AMPK AMP-activated protein kinase 
AP Action potential 
APP Amyloid precursor protein 
ASCF Artificial cerebrospinal fluid 
ATG Autophagy-related gene 
AZ Active zone 
BAR Bin/Amphiphysin/RVS (BAR) domain-containing protei 
BARA Beta-alpha repeated 
BARKOR Beclin 1-associated autophagy-related key regulator 
BATS Backor/ATG14L autophagosome targeting sequence 
BECLIN Bcl-2 interacting protein; C2, protein kinase C conserved region 2 
CAPN1 Calpain1 
CAPN2 Calpain2 
C/C Coiled coil 
CCP Clathrin-coated pit 
CCV Clathrin-coated vesicle 
CHC Clathrin heavy chain 
CIE Clathrin-independent endocytosis 
CME Clathrin-independent endocytosis 
DIV Day in vitro 
ELV Endosome-like structure/vacuole 
EM Electron microscopy 
ER Endoplasmic reticulum 
ESCRT Endosomal complex required for transport 
EtOH Ethanol 
fEPSP field excitatory postsynaptic potential 
FV Fiber volley 
Hsc70 Heat shock cognate 70 
LTD Long-term depression 




mTOR mammalian target of rapamycin 
mTORC1 mammalian target of rapamycin complex I  
MVB Multivesicular body 
NMDA N-methyl-D-aspartate receptor 








Plk2 Polo-like kinase 2 
PHLPP1 PH domain and Leucine rich repeat Protein Phosphatase1 
PPF Paired pulse facilitation 
PS Population spike 
PSD Postsynaptic density 
shCtrl Non-target control shRNA 
SV Synaptic vesicle 





RRP Readily releasable pool 
UVRAG UV radiation resistance-associated gene 
vGlut1 Vesicular glutamate transporter 1  
vGAT Vesicular GABA transporter  
VPS Vacuolar protein sorting 
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